<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet href="https://rss.buzzsprout.com/styles.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:psc="http://podlove.org/simple-chapters" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <atom:link href="https://rss.buzzsprout.com/16296.rss" rel="self" type="application/rss+xml" />
  <atom:link href="https://pubsubhubbub.appspot.com/" rel="hub" xmlns="http://www.w3.org/2005/Atom" />
  <title>ASA Biopharm&#39;s Podcast</title>

  <lastBuildDate>Tue, 10 Mar 2026 14:55:09 -0400</lastBuildDate>
  <link>http://community.amstat.org/BioP/Home/</link>
  <language>en-us</language>
  <copyright>© 2026 ASA Biopharm&#39;s Podcast</copyright>
  <podcast:locked>yes</podcast:locked>
    <podcast:guid>81b9cc08-5a31-5102-8bc2-e0b454c07a3e</podcast:guid>
  <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
  <itunes:type>episodic</itunes:type>
  <itunes:explicit>false</itunes:explicit>
  <description><![CDATA[ In this podcast  series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and  discuss current issues in Biopharmaceutical statistics.]]></description>
  <generator>Buzzsprout (https://www.buzzsprout.com)</generator>
  <itunes:keywords>Statistics, ASA, Biopharmaceutical, Biopharm</itunes:keywords>
  <itunes:owner>
    <itunes:name>American Statistical Association (ASA) Biopharm. Section</itunes:name>
  </itunes:owner>
  <image>
     <url>https://storage.buzzsprout.com/br0f5xgz3wsh6csyak2kjj2dkd8f?.jpg</url>
     <title>ASA Biopharm&#39;s Podcast</title>
     <link>http://community.amstat.org/BioP/Home/</link>
  </image>
  <itunes:image href="https://storage.buzzsprout.com/br0f5xgz3wsh6csyak2kjj2dkd8f?.jpg" />
  <itunes:category text="Science &amp; Medicine" />
  <item>
    <itunes:title>Episode 115: Steven Novick</itunes:title>
    <title>Episode 115: Steven Novick</title>
    <itunes:summary><![CDATA[Biopharmaceutical Section Chair Steven Novick discusses goals for the section.  ]]></itunes:summary>
    <description><![CDATA[<p>Biopharmaceutical Section Chair Steven Novick discusses goals for the section. </p>]]></description>
    <content:encoded><![CDATA[<p>Biopharmaceutical Section Chair Steven Novick discusses goals for the section. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/18824659-episode-115-steven-novick.mp3" length="27219885" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18824659</guid>
    <pubDate>Tue, 10 Mar 2026 14:00:00 -0400</pubDate>
    <itunes:duration>2264</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 114: 2025 Nonclinical Biostatistics Conference</itunes:title>
    <title>Episode 114: 2025 Nonclinical Biostatistics Conference</title>
    <itunes:summary><![CDATA[Rebecca Wilson, Katie Brickey, John Kolassa, Jocelyn Sendecki, Paul Faya, and Mahan Dastgiri discuss the 2025 ASA Biopharmaceutical Section Nonclinical Biostatistics Conference. ]]></itunes:summary>
    <description><![CDATA[<p>Rebecca Wilson, Katie Brickey, John Kolassa, Jocelyn Sendecki, Paul Faya, and Mahan Dastgiri discuss the 2025 ASA Biopharmaceutical Section Nonclinical Biostatistics Conference.</p>]]></description>
    <content:encoded><![CDATA[<p>Rebecca Wilson, Katie Brickey, John Kolassa, Jocelyn Sendecki, Paul Faya, and Mahan Dastgiri discuss the 2025 ASA Biopharmaceutical Section Nonclinical Biostatistics Conference.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/18618525-episode-114-2025-nonclinical-biostatistics-conference.mp3" length="20626741" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18618525</guid>
    <pubDate>Tue, 03 Feb 2026 11:00:00 -0500</pubDate>
    <itunes:duration>1714</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 113: RISW: A Look Behind the Curtain  </itunes:title>
    <title>Episode 113: RISW: A Look Behind the Curtain  </title>
    <itunes:summary><![CDATA[Erik Bloomquist, Wanjie Sun, Yingwen Dong, and Jonathan Moscovici discuss what occurs behind the curtain at the Regulatory-Industry Statistics Workshop. ]]></itunes:summary>
    <description><![CDATA[<p>Erik Bloomquist, Wanjie Sun, Yingwen Dong, and Jonathan Moscovici discuss what occurs behind the curtain at the Regulatory-Industry Statistics Workshop.</p>]]></description>
    <content:encoded><![CDATA[<p>Erik Bloomquist, Wanjie Sun, Yingwen Dong, and Jonathan Moscovici discuss what occurs behind the curtain at the Regulatory-Industry Statistics Workshop.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/17866676-episode-113-risw-a-look-behind-the-curtain.mp3" length="15736289" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17866676</guid>
    <pubDate>Thu, 18 Sep 2025 10:00:00 -0400</pubDate>
    <itunes:duration>1307</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 112: Preparing Future Statisticians to Succeed in the Era of AI</itunes:title>
    <title>Episode 112: Preparing Future Statisticians to Succeed in the Era of AI</title>
    <itunes:summary><![CDATA[John McGready discusses how to prepare future statisticians to succeed in the era of AI.  ]]></itunes:summary>
    <description><![CDATA[<p>John McGready discusses how to prepare future statisticians to succeed in the era of AI. </p>]]></description>
    <content:encoded><![CDATA[<p>John McGready discusses how to prepare future statisticians to succeed in the era of AI. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/16917179-episode-112-preparing-future-statisticians-to-succeed-in-the-era-of-ai.mp3" length="11473135" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16917179</guid>
    <pubDate>Fri, 04 Apr 2025 10:00:00 -0400</pubDate>
    <itunes:duration>951</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 111: Nan Laird</itunes:title>
    <title>Episode 111: Nan Laird</title>
    <itunes:summary><![CDATA[A look at the life and accomplishments of Nan Laird.  ]]></itunes:summary>
    <description><![CDATA[<p>A look at the life and accomplishments of Nan Laird. </p>]]></description>
    <content:encoded><![CDATA[<p>A look at the life and accomplishments of Nan Laird. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/16448511-episode-111-nan-laird.mp3" length="36048723" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16448511</guid>
    <pubDate>Thu, 16 Jan 2025 10:00:00 -0500</pubDate>
    <itunes:duration>2999</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 110: STATBOLIC Cardiometabolic Statistical Workshop</itunes:title>
    <title>Episode 110: STATBOLIC Cardiometabolic Statistical Workshop</title>
    <itunes:summary><![CDATA[Jürgen Hummel, Hiya Banerjee, Jingyi Liu, Jason Legg, and Henrik Ravn discuss the inaugural STATBOLIC Workshop. ]]></itunes:summary>
    <description><![CDATA[<p>Jürgen Hummel, Hiya Banerjee, Jingyi Liu, Jason Legg, and Henrik Ravn discuss the inaugural STATBOLIC Workshop.</p>]]></description>
    <content:encoded><![CDATA[<p>Jürgen Hummel, Hiya Banerjee, Jingyi Liu, Jason Legg, and Henrik Ravn discuss the inaugural STATBOLIC Workshop.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/16228955-episode-110-statbolic-cardiometabolic-statistical-workshop.mp3" length="19964056" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16228955</guid>
    <pubDate>Thu, 05 Dec 2024 15:00:00 -0500</pubDate>
    <itunes:duration>1659</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 109: Ian Sturdy</itunes:title>
    <title>Episode 109: Ian Sturdy</title>
    <itunes:summary><![CDATA[Ian describes how to leverage ChatGPT to accelerate statistical programming in the medical product industry.  Related paper available here: https://www.pharmasug.org/proceedings/2024/AP/PharmaSUG-2024-AP-256.pdf ]]></itunes:summary>
    <description><![CDATA[<p>Ian describes how to leverage ChatGPT to accelerate statistical programming in the medical product industry.<br/><br/>Related paper available here: https://www.pharmasug.org/proceedings/2024/AP/PharmaSUG-2024-AP-256.pdf</p>]]></description>
    <content:encoded><![CDATA[<p>Ian describes how to leverage ChatGPT to accelerate statistical programming in the medical product industry.<br/><br/>Related paper available here: https://www.pharmasug.org/proceedings/2024/AP/PharmaSUG-2024-AP-256.pdf</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/15220735-episode-109-ian-sturdy.mp3" length="24205538" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-15220735</guid>
    <pubDate>Sun, 09 Jun 2024 17:00:00 -0400</pubDate>
    <itunes:duration>2012</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 108: Working Moms</itunes:title>
    <title>Episode 108: Working Moms</title>
    <itunes:summary><![CDATA[Elaine Hoffman, Rebbecca Wilson, Christina Nurse, and Amy LaLonde discuss the balancing act between family and career. ]]></itunes:summary>
    <description><![CDATA[<p>Elaine Hoffman, Rebbecca Wilson, Christina Nurse, and Amy LaLonde discuss the balancing act between family and career.</p>]]></description>
    <content:encoded><![CDATA[<p>Elaine Hoffman, Rebbecca Wilson, Christina Nurse, and Amy LaLonde discuss the balancing act between family and career.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/15016683-episode-108-working-moms.mp3" length="26807025" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-15016683</guid>
    <pubDate>Mon, 06 May 2024 08:00:00 -0400</pubDate>
    <itunes:duration>2229</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 107: SPAIG Committee</itunes:title>
    <title>Episode 107: SPAIG Committee</title>
    <itunes:summary><![CDATA[Scott Clark,  Satrajit Roychoudhury, and Michelle Shardell discuss the Statistical Partnerships Among Academe, Industry &amp; Government (SPAIG) Committee.  https://community.amstat.org/spaig/home    ]]></itunes:summary>
    <description><![CDATA[<p>Scott Clark,  Satrajit Roychoudhury, and Michelle Shardell discuss the Statistical Partnerships Among Academe, Industry &amp; Government (SPAIG) Committee.<br/><br/>https://community.amstat.org/spaig/home<br/><br/><br/></p>]]></description>
    <content:encoded><![CDATA[<p>Scott Clark,  Satrajit Roychoudhury, and Michelle Shardell discuss the Statistical Partnerships Among Academe, Industry &amp; Government (SPAIG) Committee.<br/><br/>https://community.amstat.org/spaig/home<br/><br/><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/14471619-episode-107-spaig-committee.mp3" length="19891623" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14471619</guid>
    <pubDate>Fri, 09 Feb 2024 11:00:00 -0500</pubDate>
    <itunes:duration>1652</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 106: Rebbecca Wilson</itunes:title>
    <title>Episode 106: Rebbecca Wilson</title>
    <itunes:summary><![CDATA[Amy welcomes Rebbecca to the co-hosting chair while Christina enjoys some time off with her new baby (congrats)! The two discuss Rebbecca’s fascinating career thus far and how communication styles differ across male and female leaders. Reference: https://hbr.org/2022/12/research-men-speak-more-abstractly-than-women   ]]></itunes:summary>
    <description><![CDATA[<p>Amy welcomes Rebbecca to the co-hosting chair while Christina enjoys some time off with her new baby (congrats)! The two discuss Rebbecca’s fascinating career thus far and how communication styles differ across male and female leaders.</p><p>Reference: <a href='https://url.avanan.click/v2/___https:/hbr.org/2022/12/research-men-speak-more-abstractly-than-women___.YXAzOmxleGl0YXM6YTpvOmUwODQyZTBjZGE4ZDVhYmQzYmJjY2VjM2Q0NDIwMGMwOjY6ZGUxNDo4YjZiOTYwZGZlNmJkM2NhMDgwODMwOTU2ZTM2NWU2N2E0Mzk0Njk0YjVkYjRhMmNhOGYzZTQ3NWNkYjUzYTNkOmg6VA'>https://hbr.org/2022/12/research-men-speak-more-abstractly-than-women</a></p><p><br/></p>]]></description>
    <content:encoded><![CDATA[<p>Amy welcomes Rebbecca to the co-hosting chair while Christina enjoys some time off with her new baby (congrats)! The two discuss Rebbecca’s fascinating career thus far and how communication styles differ across male and female leaders.</p><p>Reference: <a href='https://url.avanan.click/v2/___https:/hbr.org/2022/12/research-men-speak-more-abstractly-than-women___.YXAzOmxleGl0YXM6YTpvOmUwODQyZTBjZGE4ZDVhYmQzYmJjY2VjM2Q0NDIwMGMwOjY6ZGUxNDo4YjZiOTYwZGZlNmJkM2NhMDgwODMwOTU2ZTM2NWU2N2E0Mzk0Njk0YjVkYjRhMmNhOGYzZTQ3NWNkYjUzYTNkOmg6VA'>https://hbr.org/2022/12/research-men-speak-more-abstractly-than-women</a></p><p><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/12966788-episode-106-rebbecca-wilson.mp3" length="28867192" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-12966788</guid>
    <pubDate>Fri, 02 Jun 2023 10:00:00 -0400</pubDate>
    <itunes:duration>2400</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 105: Adrian Coles and Wendy Martinez</itunes:title>
    <title>Episode 105: Adrian Coles and Wendy Martinez</title>
    <itunes:summary><![CDATA[Adrian and Wendy discuss imposter syndrome and being confident in your career. ]]></itunes:summary>
    <description><![CDATA[<p>Adrian and Wendy discuss imposter syndrome and being confident in your career.</p>]]></description>
    <content:encoded><![CDATA[<p>Adrian and Wendy discuss imposter syndrome and being confident in your career.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/12741553-episode-105-adrian-coles-and-wendy-martinez.mp3" length="31733588" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-12741553</guid>
    <pubDate>Fri, 28 Apr 2023 08:00:00 -0400</pubDate>
    <itunes:duration>2639</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 104: Steve Ruberg</itunes:title>
    <title>Episode 104: Steve Ruberg</title>
    <itunes:summary><![CDATA[In our first episode of the new year, we interview Steve Ruberg, an ASA fellow with over 35 years of experience in the biopharmaceutical industry and an active proponent of the Tripartite Estimand Approach.  ]]></itunes:summary>
    <description><![CDATA[<p>In our first episode of the new year, we interview Steve Ruberg, an ASA fellow with over 35 years of experience in the biopharmaceutical industry and an active proponent of the Tripartite Estimand Approach. </p>]]></description>
    <content:encoded><![CDATA[<p>In our first episode of the new year, we interview Steve Ruberg, an ASA fellow with over 35 years of experience in the biopharmaceutical industry and an active proponent of the Tripartite Estimand Approach. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/12062683-episode-104-steve-ruberg.mp3" length="44380786" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-12062683</guid>
    <pubDate>Tue, 17 Jan 2023 13:00:00 -0500</pubDate>
    <itunes:duration>3693</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 103: Tian Gu</itunes:title>
    <title>Episode 103: Tian Gu</title>
    <itunes:summary><![CDATA[Tian discusses her research in data integration methods and the bias arising from lack of representation. ]]></itunes:summary>
    <description><![CDATA[<p>Tian discusses her research in data integration methods and the bias arising from lack of representation.</p>]]></description>
    <content:encoded><![CDATA[<p>Tian discusses her research in data integration methods and the bias arising from lack of representation.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/11414323-episode-103-tian-gu.mp3" length="20406951" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-11414323</guid>
    <pubDate>Fri, 30 Sep 2022 10:00:00 -0400</pubDate>
    <itunes:duration>1695</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 102: LaShell Robinson</itunes:title>
    <title>Episode 102: LaShell Robinson</title>
    <itunes:summary><![CDATA[LaShell discusses diversity, equity, and inclusion in clinical trials. ]]></itunes:summary>
    <description><![CDATA[<p>LaShell discusses diversity, equity, and inclusion in clinical trials.</p>]]></description>
    <content:encoded><![CDATA[<p>LaShell discusses diversity, equity, and inclusion in clinical trials.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/11076808-episode-102-lashell-robinson.mp3" length="26525891" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-11076808</guid>
    <pubDate>Wed, 03 Aug 2022 13:00:00 -0400</pubDate>
    <itunes:duration>2205</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 101: Elizabeth Mannshardt-Hawk on Imposter Syndrome</itunes:title>
    <title>Episode 101: Elizabeth Mannshardt-Hawk on Imposter Syndrome</title>
    <itunes:summary><![CDATA[Elizabeth discusses imposter syndrome and how to manage it in your statistical career.  In collaboration with the ASA's Committee on Career Development (CCD website) .  ]]></itunes:summary>
    <description><![CDATA[<p>Elizabeth discusses imposter syndrome and how to manage it in your statistical career<em>.</em>  In collaboration with the ASA&apos;s Committee on Career Development (<a href='https://community.amstat.org/ccd/home'>CCD website</a>) . </p>]]></description>
    <content:encoded><![CDATA[<p>Elizabeth discusses imposter syndrome and how to manage it in your statistical career<em>.</em>  In collaboration with the ASA&apos;s Committee on Career Development (<a href='https://community.amstat.org/ccd/home'>CCD website</a>) . </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/10885414-episode-101-elizabeth-mannshardt-hawk-on-imposter-syndrome.mp3" length="33040530" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-10885414</guid>
    <pubDate>Thu, 30 Jun 2022 14:00:00 -0400</pubDate>
    <itunes:duration>2748</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 100: Dionne Price, ASA President-Elect</itunes:title>
    <title>Episode 100: Dionne Price, ASA President-Elect</title>
    <itunes:summary><![CDATA[Dionne talks about her journey in biostatistics and her goals for the ASA when she becomes President in 2023. ]]></itunes:summary>
    <description><![CDATA[<p>Dionne talks about her journey in biostatistics and her goals for the ASA when she becomes President in 2023.</p>]]></description>
    <content:encoded><![CDATA[<p>Dionne talks about her journey in biostatistics and her goals for the ASA when she becomes President in 2023.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/10711350-episode-100-dionne-price-asa-president-elect.mp3" length="26823779" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-10711350</guid>
    <pubDate>Tue, 31 May 2022 09:00:00 -0400</pubDate>
    <itunes:duration>2230</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 99: Amy LaLonde and Christina Nurse</itunes:title>
    <title>Episode 99: Amy LaLonde and Christina Nurse</title>
    <itunes:summary><![CDATA[This episode introduces new podcast cohosts Amy LaLonde and Christina Nurse!  They take over hosting duties starting with Episode 101. ]]></itunes:summary>
    <description><![CDATA[<p>This episode introduces new podcast cohosts Amy LaLonde and Christina Nurse!  They take over hosting duties starting with Episode 101.</p>]]></description>
    <content:encoded><![CDATA[<p>This episode introduces new podcast cohosts Amy LaLonde and Christina Nurse!  They take over hosting duties starting with Episode 101.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/10543288-episode-99-amy-lalonde-and-christina-nurse.mp3" length="24376831" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-10543288</guid>
    <pubDate>Mon, 02 May 2022 12:00:00 -0400</pubDate>
    <itunes:duration>2026</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 98: Safety Scientific Working Group</itunes:title>
    <title>Episode 98: Safety Scientific Working Group</title>
    <itunes:summary><![CDATA[James Buchanan, Judy Li, Melvin Munsaka, and Bill Wang discuss the research of the Safety Scientific Working Group and their recent edited volume "Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches."  https://tinyurl.com/2ucyer95   ]]></itunes:summary>
    <description><![CDATA[<p>James Buchanan, Judy Li, Melvin Munsaka, and Bill Wang discuss the research of the Safety Scientific Working Group and their recent edited volume &quot;Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches.&quot;  https://tinyurl.com/2ucyer95<br/><br/></p>]]></description>
    <content:encoded><![CDATA[<p>James Buchanan, Judy Li, Melvin Munsaka, and Bill Wang discuss the research of the Safety Scientific Working Group and their recent edited volume &quot;Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches.&quot;  https://tinyurl.com/2ucyer95<br/><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/10348041-episode-98-safety-scientific-working-group.mp3" length="38766643" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-10348041</guid>
    <pubDate>Wed, 30 Mar 2022 13:00:00 -0400</pubDate>
    <itunes:duration>3225</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 97 - Devan Mehrotra</itunes:title>
    <title>Episode 97 - Devan Mehrotra</title>
    <itunes:summary><![CDATA[Devan discusses the 5-STAR methodology and endpoints for COVID vaccine clinical trials. ]]></itunes:summary>
    <description><![CDATA[<p>Devan discusses the 5-STAR methodology and endpoints for COVID vaccine clinical trials.</p>]]></description>
    <content:encoded><![CDATA[<p>Devan discusses the 5-STAR methodology and endpoints for COVID vaccine clinical trials.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/10162086-episode-97-devan-mehrotra.mp3" length="35470794" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-10162086</guid>
    <pubDate>Mon, 28 Feb 2022 17:00:00 -0500</pubDate>
    <itunes:duration>2951</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 96: Alan Hartford</itunes:title>
    <title>Episode 96: Alan Hartford</title>
    <itunes:summary><![CDATA[Alan is the 2022 Chair of the Biopharmaceutical Section. He discusses his wish list for things to accomplish this year. ]]></itunes:summary>
    <description><![CDATA[<p>Alan is the 2022 Chair of the Biopharmaceutical Section. He discusses his wish list for things to accomplish this year.</p>]]></description>
    <content:encoded><![CDATA[<p>Alan is the 2022 Chair of the Biopharmaceutical Section. He discusses his wish list for things to accomplish this year.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/9988016-episode-96-alan-hartford.mp3" length="23249246" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-9988016</guid>
    <pubDate>Mon, 31 Jan 2022 18:00:00 -0500</pubDate>
    <itunes:duration>1932</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 95: Anna Nevius</itunes:title>
    <title>Episode 95: Anna Nevius</title>
    <itunes:summary><![CDATA[ Anna Nevius reflects on her time at the Center for Veterinary Medicine at the FDA and as chair of the Biopharmaceutical Section in 2009. ]]></itunes:summary>
    <description><![CDATA[<p> Anna Nevius reflects on her time at the Center for Veterinary Medicine at the FDA and as chair of the Biopharmaceutical Section in 2009.</p>]]></description>
    <content:encoded><![CDATA[<p> Anna Nevius reflects on her time at the Center for Veterinary Medicine at the FDA and as chair of the Biopharmaceutical Section in 2009.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/9638242-episode-95-anna-nevius.mp3" length="22580298" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-9638242</guid>
    <pubDate>Tue, 30 Nov 2021 13:00:00 -0500</pubDate>
    <itunes:duration>1876</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 94: Bob Starbuck</itunes:title>
    <title>Episode 94: Bob Starbuck</title>
    <itunes:summary><![CDATA[Bob Starbuck reflects on his time as chair of the Biopharmaceutical Section in 1994. ]]></itunes:summary>
    <description><![CDATA[<p>Bob Starbuck reflects on his time as chair of the Biopharmaceutical Section in 1994.</p>]]></description>
    <content:encoded><![CDATA[<p>Bob Starbuck reflects on his time as chair of the Biopharmaceutical Section in 1994.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/9455561-episode-94-bob-starbuck.mp3" length="24887121" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-9455561</guid>
    <pubDate>Fri, 29 Oct 2021 09:00:00 -0400</pubDate>
    <itunes:duration>2069</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 93: External Control Arms</itunes:title>
    <title>Episode 93: External Control Arms</title>
    <itunes:summary><![CDATA[Amy Xia and Lanju Zhang discuss the benefits and challenges of utilizing external control arms for clinical trials. ]]></itunes:summary>
    <description><![CDATA[<p>Amy Xia and Lanju Zhang discuss the benefits and challenges of utilizing external control arms for clinical trials.</p>]]></description>
    <content:encoded><![CDATA[<p>Amy Xia and Lanju Zhang discuss the benefits and challenges of utilizing external control arms for clinical trials.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/9287930-episode-93-external-control-arms.mp3" length="38860664" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-9287930</guid>
    <pubDate>Thu, 30 Sep 2021 12:00:00 -0400</pubDate>
    <itunes:duration>3233</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 92: 2021 Regulatory-Industry Statistics Workshop</itunes:title>
    <title>Episode 92: 2021 Regulatory-Industry Statistics Workshop</title>
    <itunes:summary><![CDATA[Bo Huang and Gene Pennello discuss the 2021 Regulatory-Industry Statistics Workshop. ]]></itunes:summary>
    <description><![CDATA[<p>Bo Huang and Gene Pennello discuss the 2021 Regulatory-Industry Statistics Workshop.</p>]]></description>
    <content:encoded><![CDATA[<p>Bo Huang and Gene Pennello discuss the 2021 Regulatory-Industry Statistics Workshop.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/9044598-episode-92-2021-regulatory-industry-statistics-workshop.mp3" length="25872419" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-9044598</guid>
    <pubDate>Tue, 17 Aug 2021 15:00:00 -0400</pubDate>
    <itunes:duration>2151</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 91: Patient Reported Outcomes</itunes:title>
    <title>Episode 91: Patient Reported Outcomes</title>
    <itunes:summary><![CDATA[Joseph Cappelleri and Daniel O’Connor discuss the benefits and challenges in using patient reported outcomes and how to appropriately define clinically-meaningful change. ]]></itunes:summary>
    <description><![CDATA[<p>Joseph Cappelleri and Daniel O’Connor discuss the benefits and challenges in using patient reported outcomes and how to appropriately define clinically-meaningful change.</p>]]></description>
    <content:encoded><![CDATA[<p>Joseph Cappelleri and Daniel O’Connor discuss the benefits and challenges in using patient reported outcomes and how to appropriately define clinically-meaningful change.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/8864025-episode-91-patient-reported-outcomes.mp3" length="44756091" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8864025</guid>
    <pubDate>Fri, 30 Jul 2021 06:00:00 -0400</pubDate>
    <itunes:duration>3724</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 90: ICSA Leadership Panel</itunes:title>
    <title>Episode 90: ICSA Leadership Panel</title>
    <itunes:summary><![CDATA[Haoda Fu, Mengling Liu, Jie Tang, Tian Zheng, and Kelly Zou discuss leadership and the impact of COVID-19 on the workplace. ]]></itunes:summary>
    <description><![CDATA[<p>Haoda Fu, Mengling Liu, Jie Tang, Tian Zheng, and Kelly Zou discuss leadership and the impact of COVID-19 on the workplace.</p>]]></description>
    <content:encoded><![CDATA[<p>Haoda Fu, Mengling Liu, Jie Tang, Tian Zheng, and Kelly Zou discuss leadership and the impact of COVID-19 on the workplace.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/8791589-episode-90-icsa-leadership-panel.mp3" length="22840184" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8791589</guid>
    <pubDate>Wed, 30 Jun 2021 16:00:00 -0400</pubDate>
    <itunes:duration>1898</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 89: Karl Peace</itunes:title>
    <title>Episode 89: Karl Peace</title>
    <itunes:summary><![CDATA[Karl Peace was chair of the Biopharmaceutical Section in 1990. He discusses his career in the industry, the Jiann-Ping Hsu College of Public Health, and the Biopharmaceutical Applied Statistics Symposium. ]]></itunes:summary>
    <description><![CDATA[<p>Karl Peace was chair of the Biopharmaceutical Section in 1990. He discusses his career in the industry, the Jiann-Ping Hsu College of Public Health, and the Biopharmaceutical Applied Statistics Symposium.</p>]]></description>
    <content:encoded><![CDATA[<p>Karl Peace was chair of the Biopharmaceutical Section in 1990. He discusses his career in the industry, the Jiann-Ping Hsu College of Public Health, and the Biopharmaceutical Applied Statistics Symposium.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/8619835-episode-89-karl-peace.mp3" length="34415646" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8619835</guid>
    <pubDate>Mon, 31 May 2021 16:00:00 -0400</pubDate>
    <itunes:duration>2863</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 88: Katherine Monti</itunes:title>
    <title>Episode 88: Katherine Monti</title>
    <itunes:summary><![CDATA[Katherine Monti was chair of the Biopharmaceutical Section in 2010. She discusses her career in the industry and how the Section has changed over time.  ]]></itunes:summary>
    <description><![CDATA[<p>Katherine Monti was chair of the Biopharmaceutical Section in 2010. She discusses her career in the industry and how the Section has changed over time. </p>]]></description>
    <content:encoded><![CDATA[<p>Katherine Monti was chair of the Biopharmaceutical Section in 2010. She discusses her career in the industry and how the Section has changed over time. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/8436722-episode-88-katherine-monti.mp3" length="40981214" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8436722</guid>
    <pubDate>Fri, 30 Apr 2021 16:00:00 -0400</pubDate>
    <itunes:duration>3410</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 87: Storytelling</itunes:title>
    <title>Episode 87: Storytelling</title>
    <itunes:summary><![CDATA[Scott Evans, Stephanie Omokaro, Janet Wittes, and Zhiheng Xu discuss the importance of storytelling for the modern statistician.    ]]></itunes:summary>
    <description><![CDATA[<p>Scott Evans, Stephanie Omokaro, Janet Wittes, and Zhiheng Xu discuss the importance of storytelling for the modern statistician. <br/><br/></p>]]></description>
    <content:encoded><![CDATA[<p>Scott Evans, Stephanie Omokaro, Janet Wittes, and Zhiheng Xu discuss the importance of storytelling for the modern statistician. <br/><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/8247537-episode-87-storytelling.mp3" length="46847744" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8247537</guid>
    <pubDate>Wed, 31 Mar 2021 11:00:00 -0400</pubDate>
    <itunes:duration>3899</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 86: Pediatric Drug Development Scientific Working Group</itunes:title>
    <title>Episode 86: Pediatric Drug Development Scientific Working Group</title>
    <itunes:summary><![CDATA[Meg Gamalo and Jingjing Ye talk about pediatric drug development and discuss why forming a scientific working group was so important. ]]></itunes:summary>
    <description><![CDATA[<p>Meg Gamalo and Jingjing Ye talk about pediatric drug development and discuss why forming a scientific working group was so important.</p>]]></description>
    <content:encoded><![CDATA[<p>Meg Gamalo and Jingjing Ye talk about pediatric drug development and discuss why forming a scientific working group was so important.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/8029764-episode-86-pediatric-drug-development-scientific-working-group.mp3" length="34004981" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8029764</guid>
    <pubDate>Thu, 25 Feb 2021 13:00:00 -0500</pubDate>
    <itunes:duration>2829</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 85: Weili He</itunes:title>
    <title>Episode 85: Weili He</title>
    <itunes:summary><![CDATA[Weili talks about publishing, leadership, and her hopes and plans for the Biopharmaceutical Section in 2021. ]]></itunes:summary>
    <description><![CDATA[<p>Weili talks about publishing, leadership, and her hopes and plans for the Biopharmaceutical Section in 2021.</p>]]></description>
    <content:encoded><![CDATA[<p>Weili talks about publishing, leadership, and her hopes and plans for the Biopharmaceutical Section in 2021.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/7563430-episode-85-weili-he.mp3" length="29481211" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-7563430</guid>
    <pubDate>Fri, 29 Jan 2021 15:00:00 -0500</pubDate>
    <itunes:duration>2452</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 84: David Salsburg</itunes:title>
    <title>Episode 84: David Salsburg</title>
    <itunes:summary><![CDATA[David shares some of his experiences as the first statistician ever hired at Pfizer. ]]></itunes:summary>
    <description><![CDATA[<p>David shares some of his experiences as the first statistician ever hired at Pfizer.</p>]]></description>
    <content:encoded><![CDATA[<p>David shares some of his experiences as the first statistician ever hired at Pfizer.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/7087042-episode-84-david-salsburg.mp3" length="33195567" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-7087042</guid>
    <pubDate>Thu, 31 Dec 2020 22:00:00 -0500</pubDate>
    <itunes:duration>2761</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 83: Vaccine Development</itunes:title>
    <title>Episode 83: Vaccine Development</title>
    <itunes:summary><![CDATA[Kerry Go and Elaine Hoffman discuss vaccine development. ]]></itunes:summary>
    <description><![CDATA[<p>Kerry Go and Elaine Hoffman discuss vaccine development.</p>]]></description>
    <content:encoded><![CDATA[<p>Kerry Go and Elaine Hoffman discuss vaccine development.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/6623449-episode-83-vaccine-development.mp3" length="25559140" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-6623449</guid>
    <pubDate>Mon, 30 Nov 2020 17:00:00 -0500</pubDate>
    <itunes:duration>2125</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 82: Olga Marchenko and Natallia Katenka</itunes:title>
    <title>Episode 82: Olga Marchenko and Natallia Katenka</title>
    <itunes:summary><![CDATA[Olga and Natallia discuss their new book Quantitative Methods in Pharmaceutical Research and Development: Concepts and Applications.  ]]></itunes:summary>
    <description><![CDATA[<p>Olga and Natallia discuss their new book <em>Quantitative Methods in Pharmaceutical Research and Development: Concepts and Applications</em>. </p>]]></description>
    <content:encoded><![CDATA[<p>Olga and Natallia discuss their new book <em>Quantitative Methods in Pharmaceutical Research and Development: Concepts and Applications</em>. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/6148396-episode-82-olga-marchenko-and-natallia-katenka.mp3" length="35692351" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-6148396</guid>
    <pubDate>Fri, 30 Oct 2020 16:00:00 -0400</pubDate>
    <itunes:duration>2969</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 81: Mentor-Mentee Pairs from the BIOP Mentoring Program</itunes:title>
    <title>Episode 81: Mentor-Mentee Pairs from the BIOP Mentoring Program</title>
    <itunes:summary><![CDATA[This episode features discussions with 3 mentor-mentee pairs from the Biopharmaceutical Section mentoring program. Conversations include Qing Li and Abie Ekangaki (start 1:25), Samson Ghebremariam and Scott Clark (start 44:33), and Carie Kimbrough and Bruce Binkowitz (start 102:29). They discuss the benefits of mentoring and the dynamics of the mentoring relationship.  ]]></itunes:summary>
    <description><![CDATA[<p>This episode features discussions with 3 mentor-mentee pairs from the Biopharmaceutical Section mentoring program. Conversations include Qing Li and Abie Ekangaki (start 1:25), Samson Ghebremariam and Scott Clark (start 44:33), and Carie Kimbrough and Bruce Binkowitz (start 102:29). They discuss the benefits of mentoring and the dynamics of the mentoring relationship. </p>]]></description>
    <content:encoded><![CDATA[<p>This episode features discussions with 3 mentor-mentee pairs from the Biopharmaceutical Section mentoring program. Conversations include Qing Li and Abie Ekangaki (start 1:25), Samson Ghebremariam and Scott Clark (start 44:33), and Carie Kimbrough and Bruce Binkowitz (start 102:29). They discuss the benefits of mentoring and the dynamics of the mentoring relationship. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/5682304-episode-81-mentor-mentee-pairs-from-the-biop-mentoring-program.mp3" length="74169406" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-5682304</guid>
    <pubDate>Wed, 30 Sep 2020 17:00:00 -0400</pubDate>
    <itunes:duration>6176</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 80: 2020 Regulatory-Industry Statistics Workshop</itunes:title>
    <title>Episode 80: 2020 Regulatory-Industry Statistics Workshop</title>
    <itunes:summary><![CDATA[Yabing Mai and Thomas Birkner discuss the 2020 Workshop and the changes necessary to go virtual. ]]></itunes:summary>
    <description><![CDATA[<p>Yabing Mai and Thomas Birkner discuss the 2020 Workshop and the changes necessary to go virtual.</p>]]></description>
    <content:encoded><![CDATA[<p>Yabing Mai and Thomas Birkner discuss the 2020 Workshop and the changes necessary to go virtual.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/5225302-episode-80-2020-regulatory-industry-statistics-workshop.mp3" length="34411457" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-5225302</guid>
    <pubDate>Mon, 31 Aug 2020 10:00:00 -0400</pubDate>
    <itunes:duration>2862</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 79: Nusrat Rabbee</itunes:title>
    <title>Episode 79: Nusrat Rabbee</title>
    <itunes:summary><![CDATA[Nusrat discusses biomarker analysis throughout clinical development and her recent book Biomarker Analysis in Clinical Trials with R. ]]></itunes:summary>
    <description><![CDATA[<p>Nusrat discusses biomarker analysis throughout clinical development and her recent book Biomarker Analysis in Clinical Trials with R.</p>]]></description>
    <content:encoded><![CDATA[<p>Nusrat discusses biomarker analysis throughout clinical development and her recent book Biomarker Analysis in Clinical Trials with R.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/4796051-episode-79-nusrat-rabbee.mp3" length="48590618" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-4796051</guid>
    <pubDate>Fri, 31 Jul 2020 11:00:00 -0400</pubDate>
    <itunes:duration>4044</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 78: Challenges with Pain Assessments</itunes:title>
    <title>Episode 78: Challenges with Pain Assessments</title>
    <itunes:summary><![CDATA[Dottie Brown, Ciprian Crainiceanu, and Jean Recta discuss how pain is quantified in human and animal trials. ]]></itunes:summary>
    <description><![CDATA[<p>Dottie Brown, Ciprian Crainiceanu, and Jean Recta discuss how pain is quantified in human and animal trials.</p>]]></description>
    <content:encoded><![CDATA[<p>Dottie Brown, Ciprian Crainiceanu, and Jean Recta discuss how pain is quantified in human and animal trials.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/4368632-episode-78-challenges-with-pain-assessments.mp3" length="38996688" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-4368632</guid>
    <pubDate>Tue, 30 Jun 2020 07:00:00 -0400</pubDate>
    <itunes:duration>3245</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 77: National Institute of Statistical Sciences</itunes:title>
    <title>Episode 77: National Institute of Statistical Sciences</title>
    <itunes:summary><![CDATA[Nancy Flournoy, Dan Holder, and Jim Rosenberger discuss the mission and history of the National Institute of Statistical Sciences and how it will adapt for the future. ]]></itunes:summary>
    <description><![CDATA[<p>Nancy Flournoy, Dan Holder, and Jim Rosenberger discuss the mission and history of the National Institute of Statistical Sciences and how it will adapt for the future.</p>]]></description>
    <content:encoded><![CDATA[<p>Nancy Flournoy, Dan Holder, and Jim Rosenberger discuss the mission and history of the National Institute of Statistical Sciences and how it will adapt for the future.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/3969683-episode-77-national-institute-of-statistical-sciences.mp3" length="39126740" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-3969683</guid>
    <pubDate>Fri, 29 May 2020 16:00:00 -0400</pubDate>
    <itunes:duration>3255</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 76: COVID-19 and Clinical Trials</itunes:title>
    <title>Episode 76: COVID-19 and Clinical Trials</title>
    <itunes:summary><![CDATA[Mouna Akacha, Yongming Qu, and Aileen Ward discuss COVID-19 and the operational and statistical effects on clinical trials. ]]></itunes:summary>
    <description><![CDATA[<p>Mouna Akacha, Yongming Qu, and Aileen Ward discuss COVID-19 and the operational and statistical effects on clinical trials.</p>]]></description>
    <content:encoded><![CDATA[<p>Mouna Akacha, Yongming Qu, and Aileen Ward discuss COVID-19 and the operational and statistical effects on clinical trials.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/3372292-episode-76-covid-19-and-clinical-trials.mp3" length="33704945" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-3372292</guid>
    <pubDate>Wed, 15 Apr 2020 12:00:00 -0400</pubDate>
    <itunes:duration>2804</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 75: Meijuan Li</itunes:title>
    <title>Episode 75: Meijuan Li</title>
    <itunes:summary><![CDATA[Meijuan Li discusses precision medicine, diagnostic devices, and the importance of parallel development of drugs and diagnostics.  ]]></itunes:summary>
    <description><![CDATA[<p>Meijuan Li discusses precision medicine, diagnostic devices, and the importance of parallel development of drugs and diagnostics. </p>]]></description>
    <content:encoded><![CDATA[<p>Meijuan Li discusses precision medicine, diagnostic devices, and the importance of parallel development of drugs and diagnostics. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/3164545-episode-75-meijuan-li.mp3" length="37973735" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-3164545</guid>
    <pubDate>Tue, 31 Mar 2020 09:00:00 -0400</pubDate>
    <itunes:duration>3159</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 74: Glen Colopy and the Pod of Asclepius</itunes:title>
    <title>Episode 74: Glen Colopy and the Pod of Asclepius</title>
    <itunes:summary><![CDATA[Glen discusses his graduate training in data science in the United Kingdom, vital sign monitoring, the challenges of efficient drug supply, and his healthcare technology podcast, the Pod of Asclepius.   ]]></itunes:summary>
    <description><![CDATA[<p>Glen discusses his graduate training in data science in the United Kingdom, vital sign monitoring, the challenges of efficient drug supply, and his healthcare technology podcast, the Pod of Asclepius.</p><p> </p>]]></description>
    <content:encoded><![CDATA[<p>Glen discusses his graduate training in data science in the United Kingdom, vital sign monitoring, the challenges of efficient drug supply, and his healthcare technology podcast, the Pod of Asclepius.</p><p> </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/2867941-episode-74-glen-colopy-and-the-pod-of-asclepius.mp3" length="34137798" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-2867941</guid>
    <pubDate>Fri, 28 Feb 2020 09:00:00 -0500</pubDate>
    <itunes:duration>2840</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 73: Bruce Binkowitz</itunes:title>
    <title>Episode 73: Bruce Binkowitz</title>
    <itunes:summary><![CDATA[Bruce discusses the Japanese regulatory environment, challenges for statistics departments spread across the globe, and his hopes and plans for the Biopharmaceutical Section in 2020. ]]></itunes:summary>
    <description><![CDATA[<p>Bruce discusses the Japanese regulatory environment, challenges for statistics departments spread across the globe, and his hopes and plans for the Biopharmaceutical Section in 2020.</p>]]></description>
    <content:encoded><![CDATA[<p>Bruce discusses the Japanese regulatory environment, challenges for statistics departments spread across the globe, and his hopes and plans for the Biopharmaceutical Section in 2020.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/2646412-episode-73-bruce-binkowitz.mp3" length="32104402" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-2646412</guid>
    <pubDate>Mon, 03 Feb 2020 10:00:00 -0500</pubDate>
    <itunes:duration>2670</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 72: Abie Ekangaki</itunes:title>
    <title>Episode 72: Abie Ekangaki</title>
    <itunes:summary><![CDATA[Abie discusses opportunities for statisticians in the CRO industry, and we chat about the Scholarship and Leadership-in-Practice Committees of the Biopharmaceutical Section. ]]></itunes:summary>
    <description><![CDATA[<p>Abie discusses opportunities for statisticians in the CRO industry, and we chat about the Scholarship and Leadership-in-Practice Committees of the Biopharmaceutical Section.</p>]]></description>
    <content:encoded><![CDATA[<p>Abie discusses opportunities for statisticians in the CRO industry, and we chat about the Scholarship and Leadership-in-Practice Committees of the Biopharmaceutical Section.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/2384201-episode-72-abie-ekangaki.mp3" length="40406617" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-2384201</guid>
    <pubDate>Tue, 31 Dec 2019 15:00:00 -0500</pubDate>
    <itunes:duration>3362</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 71: P-values in Medical Product Development</itunes:title>
    <title>Episode 71: P-values in Medical Product Development</title>
    <itunes:summary><![CDATA[Lisa LaVange, J. Jack Lee, and Steve Ruberg about the ASA Statement on p-values, and their recent paper entitled “Inference and Decision Making for 21st-Century Drug Development and Approval” which was featured in the American Statistician in early 2019.  ]]></itunes:summary>
    <description><![CDATA[<p>Lisa LaVange, J. Jack Lee, and Steve Ruberg about the ASA Statement on p-values, and their recent paper entitled “Inference and Decision Making for 21st-Century Drug Development and Approval” which was featured in the American Statistician in early 2019. </p>]]></description>
    <content:encoded><![CDATA[<p>Lisa LaVange, J. Jack Lee, and Steve Ruberg about the ASA Statement on p-values, and their recent paper entitled “Inference and Decision Making for 21st-Century Drug Development and Approval” which was featured in the American Statistician in early 2019. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/2205803-episode-71-p-values-in-medical-product-development.mp3" length="42638461" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-2205803</guid>
    <pubDate>Mon, 02 Dec 2019 09:00:00 -0500</pubDate>
    <itunes:duration>3548</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 70: 2020 International Conference on Health Policy Statistics</itunes:title>
    <title>Episode 70: 2020 International Conference on Health Policy Statistics</title>
    <itunes:summary><![CDATA[Kate Crespi and Ofer Harel discuss the 2020 International Conference on Health Policy Statistics, and describe current topics of interest in health policy including gun violence and opioids.  ]]></itunes:summary>
    <description><![CDATA[<p>Kate Crespi and Ofer Harel discuss the 2020 International Conference on Health Policy Statistics, and describe current topics of interest in health policy including gun violence and opioids. </p>]]></description>
    <content:encoded><![CDATA[<p>Kate Crespi and Ofer Harel discuss the 2020 International Conference on Health Policy Statistics, and describe current topics of interest in health policy including gun violence and opioids. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/1967815-episode-70-2020-international-conference-on-health-policy-statistics.mp3" length="32847351" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-1967815</guid>
    <pubDate>Thu, 31 Oct 2019 09:00:00 -0400</pubDate>
    <itunes:duration>2732</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 69: Non-proportional Hazards</itunes:title>
    <title>Episode 69: Non-proportional Hazards</title>
    <itunes:summary><![CDATA[Keaven Anderson, Pralay Mukhopadhyay, and Satrajit Roychoudhury discuss non-proportional hazards in a regulatory setting. ]]></itunes:summary>
    <description><![CDATA[<p>Keaven Anderson, Pralay Mukhopadhyay, and Satrajit Roychoudhury discuss non-proportional hazards in a regulatory setting.</p>]]></description>
    <content:encoded><![CDATA[<p>Keaven Anderson, Pralay Mukhopadhyay, and Satrajit Roychoudhury discuss non-proportional hazards in a regulatory setting.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/1789918-episode-69-non-proportional-hazards.mp3" length="36623964" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-1789918</guid>
    <pubDate>Mon, 30 Sep 2019 09:00:00 -0400</pubDate>
    <itunes:duration>3047</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 68: 2019 Regulatory-Industry Statistics Workshop</itunes:title>
    <title>Episode 68: 2019 Regulatory-Industry Statistics Workshop</title>
    <itunes:summary><![CDATA[Judy Li and Renee Rees discuss what's new and exciting at the 2019 Regulatory-Industry Statistics Workshop. ]]></itunes:summary>
    <description><![CDATA[<p>Judy Li and Renee Rees discuss what&apos;s new and exciting at the 2019 Regulatory-Industry Statistics Workshop.</p>]]></description>
    <content:encoded><![CDATA[<p>Judy Li and Renee Rees discuss what&apos;s new and exciting at the 2019 Regulatory-Industry Statistics Workshop.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/1627915-episode-68-2019-regulatory-industry-statistics-workshop.mp3" length="32059496" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-1627915</guid>
    <pubDate>Fri, 30 Aug 2019 09:00:00 -0400</pubDate>
    <itunes:duration>2666</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 67: Task Force on Sexual Harassment and Assault</itunes:title>
    <title>Episode 67: Task Force on Sexual Harassment and Assault</title>
    <itunes:summary><![CDATA[Donna LaLonde, Kristian Lum, and Leslie McClure discuss the ASA Task Force on Sexual Harassment and Assault. ]]></itunes:summary>
    <description><![CDATA[<p>Donna LaLonde, Kristian Lum, and Leslie McClure discuss the ASA Task Force on Sexual Harassment and Assault.</p>]]></description>
    <content:encoded><![CDATA[<p>Donna LaLonde, Kristian Lum, and Leslie McClure discuss the ASA Task Force on Sexual Harassment and Assault.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/1476757-episode-67-task-force-on-sexual-harassment-and-assault.mp3" length="37020541" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-1476757</guid>
    <pubDate>Mon, 29 Jul 2019 18:00:00 -0400</pubDate>
    <itunes:duration>3080</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 66: Quality Tolerance Limits</itunes:title>
    <title>Episode 66: Quality Tolerance Limits</title>
    <itunes:summary><![CDATA[Rakhi Kilaru and Olgica Klindworth discuss risk-based monitoring and quality tolerance limits.  ]]></itunes:summary>
    <description><![CDATA[<p>Rakhi Kilaru and Olgica Klindworth discuss risk-based monitoring and quality tolerance limits. </p>]]></description>
    <content:encoded><![CDATA[<p>Rakhi Kilaru and Olgica Klindworth discuss risk-based monitoring and quality tolerance limits. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/1341031-episode-66-quality-tolerance-limits.mp3" length="29339209" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-1341031</guid>
    <pubDate>Fri, 28 Jun 2019 09:00:00 -0400</pubDate>
    <itunes:duration>2440</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 65: Immuno-oncology</itunes:title>
    <title>Episode 65: Immuno-oncology</title>
    <itunes:summary><![CDATA[Inna Perevozskaya and Bo Huang discuss the changing landscape in oncology clinical development.  ]]></itunes:summary>
    <description><![CDATA[<p>Inna Perevozskaya and Bo Huang discuss the changing landscape in oncology clinical development. </p>]]></description>
    <content:encoded><![CDATA[<p>Inna Perevozskaya and Bo Huang discuss the changing landscape in oncology clinical development. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/1219433-episode-65-immuno-oncology.mp3" length="22340085" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-1219433</guid>
    <pubDate>Fri, 31 May 2019 08:00:00 -0400</pubDate>
    <itunes:duration>2785</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 64: Biopharmaceutical Software Scientific Working Group</itunes:title>
    <title>Episode 64: Biopharmaceutical Software Scientific Working Group</title>
    <itunes:summary><![CDATA[Alex Dmitrienko and Kyle Wathen talk about the development of software for biopharmaceutical applications, the new working group and LinkedIn group, and talk a little bit about the new YouTube Channel for the Biopharmaceutical Section.        ]]></itunes:summary>
    <description><![CDATA[<p>Alex Dmitrienko and Kyle Wathen talk about the development of software for biopharmaceutical applications, the new <a href='https://community.amstat.org/biop/workinggroups/biopharmsoft/biopharmsoft-home'>working group</a> and <a href='https://www.linkedin.com/groups/13665934/'>LinkedIn group</a>, and talk a little bit about the new <a href='https://www.youtube.com/channel/UC3Tkg5b3QR8fXWsTBYerCng'>YouTube Channel</a> for the Biopharmaceutical Section.<br/><br/><br/><br/><br/><br/><br/></p>]]></description>
    <content:encoded><![CDATA[<p>Alex Dmitrienko and Kyle Wathen talk about the development of software for biopharmaceutical applications, the new <a href='https://community.amstat.org/biop/workinggroups/biopharmsoft/biopharmsoft-home'>working group</a> and <a href='https://www.linkedin.com/groups/13665934/'>LinkedIn group</a>, and talk a little bit about the new <a href='https://www.youtube.com/channel/UC3Tkg5b3QR8fXWsTBYerCng'>YouTube Channel</a> for the Biopharmaceutical Section.<br/><br/><br/><br/><br/><br/><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/1069370-episode-64-biopharmaceutical-software-scientific-working-group.mp3" length="25347830" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-1069370</guid>
    <pubDate>Tue, 30 Apr 2019 08:00:00 -0400</pubDate>
    <itunes:duration>3159</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 63: Platform Trials</itunes:title>
    <title>Episode 63: Platform Trials</title>
    <itunes:summary><![CDATA[Zoran Antonijevic, Robert Beckman, Scott Berry &amp; Richard Simon discuss the current application and future of platform trials.   ]]></itunes:summary>
    <description><![CDATA[<p>Zoran Antonijevic, Robert Beckman, Scott Berry &amp; Richard Simon discuss the current application and future of platform trials.  </p>]]></description>
    <content:encoded><![CDATA[<p>Zoran Antonijevic, Robert Beckman, Scott Berry &amp; Richard Simon discuss the current application and future of platform trials.  </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/1016034-episode-63-platform-trials.mp3" length="27254466" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-1016034</guid>
    <pubDate>Fri, 29 Mar 2019 00:00:00 -0400</pubDate>
    <itunes:duration>3398</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 62: Qi Tang</itunes:title>
    <title>Episode 62: Qi Tang</title>
    <itunes:summary><![CDATA[Qi talks about the benefits and challenges of applying deep learning methodologies to electronic medical records. ]]></itunes:summary>
    <description><![CDATA[<p>Qi talks about the benefits and challenges of applying deep learning methodologies to electronic medical records.</p>]]></description>
    <content:encoded><![CDATA[<p>Qi talks about the benefits and challenges of applying deep learning methodologies to electronic medical records.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/975812-episode-62-qi-tang.mp3" length="20611011" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-975812</guid>
    <pubDate>Thu, 28 Feb 2019 00:00:00 -0500</pubDate>
    <itunes:duration>2567</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 61: Richard C. Zink</itunes:title>
    <title>Episode 61: Richard C. Zink</title>
    <itunes:summary><![CDATA[Richard discusses the importance of the Biopharmaceutical Section and describes what he hopes to accomplish as Chair in 2019. ]]></itunes:summary>
    <description><![CDATA[<p>Richard discusses the importance of the Biopharmaceutical Section and describes what he hopes to accomplish as Chair in 2019.</p>]]></description>
    <content:encoded><![CDATA[<p>Richard discusses the importance of the Biopharmaceutical Section and describes what he hopes to accomplish as Chair in 2019.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/940008-episode-61-richard-c-zink.mp3" length="25986609" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-940008</guid>
    <pubDate>Thu, 31 Jan 2019 00:00:00 -0500</pubDate>
    <itunes:duration>3239</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 60: Toshimitsu Hamasaki</itunes:title>
    <title>Episode 60: Toshimitsu Hamasaki</title>
    <itunes:summary><![CDATA[Toshimitsu Hamasaki describes his work at a major research hospital and discusses the regulatory environment in Japan. ]]></itunes:summary>
    <description><![CDATA[<p>Toshimitsu Hamasaki describes his work at a major research hospital and discusses the regulatory environment in Japan.</p>]]></description>
    <content:encoded><![CDATA[<p>Toshimitsu Hamasaki describes his work at a major research hospital and discusses the regulatory environment in Japan.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/904902-episode-60-toshimitsu-hamasaki.mp3" length="13764654" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-904902</guid>
    <pubDate>Mon, 31 Dec 2018 11:00:00 -0500</pubDate>
    <itunes:duration>1711</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 59: Alzheimer&#39;s Disease Scientific Working Group</itunes:title>
    <title>Episode 59: Alzheimer&#39;s Disease Scientific Working Group</title>
    <itunes:summary><![CDATA[Hong Liu-Seifert and Steve Wilson discuss the challenges of developing new treatments for Alzheimer's Disease and the formation of the scientific working group. ]]></itunes:summary>
    <description><![CDATA[<p>Hong Liu-Seifert and Steve Wilson discuss the challenges of developing new treatments for Alzheimer&apos;s Disease and the formation of the scientific working group.</p>]]></description>
    <content:encoded><![CDATA[<p>Hong Liu-Seifert and Steve Wilson discuss the challenges of developing new treatments for Alzheimer&apos;s Disease and the formation of the scientific working group.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/875381-episode-59-alzheimer-s-disease-scientific-working-group.mp3" length="22964613" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-875381</guid>
    <pubDate>Fri, 30 Nov 2018 10:00:00 -0500</pubDate>
    <itunes:duration>2861</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 58: SPAIG (Statistical Partnerships Among Academe, Industry &amp; Government)</itunes:title>
    <title>Episode 58: SPAIG (Statistical Partnerships Among Academe, Industry &amp; Government)</title>
    <itunes:summary><![CDATA[Pam McGovern, Willis Jensen, John Kolassa, and Fanni Natanegara talk about collaboration and the Statistical Partnerships Among Academe, Industry &amp; Government Committee, otherwise known as SPAIG.  ]]></itunes:summary>
    <description><![CDATA[<p>Pam McGovern, Willis Jensen, John Kolassa, and Fanni Natanegara talk about collaboration and the Statistical Partnerships Among Academe, Industry &amp; Government Committee, otherwise known as SPAIG. </p>]]></description>
    <content:encoded><![CDATA[<p>Pam McGovern, Willis Jensen, John Kolassa, and Fanni Natanegara talk about collaboration and the Statistical Partnerships Among Academe, Industry &amp; Government Committee, otherwise known as SPAIG. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/846743-episode-58-spaig-statistical-partnerships-among-academe-industry-government.mp3" length="12609515" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-846743</guid>
    <pubDate>Wed, 31 Oct 2018 00:00:00 -0400</pubDate>
    <itunes:duration>1567</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 57: Personalized Medicine and Wearable Devices</itunes:title>
    <title>Episode 57: Personalized Medicine and Wearable Devices</title>
    <itunes:summary><![CDATA[Shanthi Sethuraman and Haoda Fu discuss challenges and opportunities in using wearable devices for research in diabetes.]]></itunes:summary>
    <description><![CDATA[Shanthi Sethuraman and Haoda Fu discuss challenges and opportunities in using wearable devices for research in diabetes.]]></description>
    <content:encoded><![CDATA[Shanthi Sethuraman and Haoda Fu discuss challenges and opportunities in using wearable devices for research in diabetes.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/815766-episode-57-personalized-medicine-and-wearable-devices.mp3" length="16721134" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-815766</guid>
    <pubDate>Fri, 28 Sep 2018 00:00:00 -0400</pubDate>
    <itunes:duration>2081</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 56: Yun Wang and Satrajit Roychoudhury</itunes:title>
    <title>Episode 56: Yun Wang and Satrajit Roychoudhury</title>
    <itunes:summary><![CDATA[Yun and Satrajit discuss the 2018 Regulatory-Industry Statistics Workshop.]]></itunes:summary>
    <description><![CDATA[Yun and Satrajit discuss the 2018 Regulatory-Industry Statistics Workshop.]]></description>
    <content:encoded><![CDATA[Yun and Satrajit discuss the 2018 Regulatory-Industry Statistics Workshop.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/787319-episode-56-yun-wang-and-satrajit-roychoudhury.mp3" length="21137275" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-787319</guid>
    <pubDate>Mon, 27 Aug 2018 00:00:00 -0400</pubDate>
    <itunes:duration>2633</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 55: Data Monitoring Committees</itunes:title>
    <title>Episode 55: Data Monitoring Committees</title>
    <itunes:summary><![CDATA[Aparna Anderson, David DeMets, Susan Ellenberg, and Janet Wittes discuss the history of data monitoring committees and some of the challenges of implementing them in practice.]]></itunes:summary>
    <description><![CDATA[Aparna Anderson, David DeMets, Susan Ellenberg, and Janet Wittes discuss the history of data monitoring committees and some of the challenges of implementing them in practice.]]></description>
    <content:encoded><![CDATA[Aparna Anderson, David DeMets, Susan Ellenberg, and Janet Wittes discuss the history of data monitoring committees and some of the challenges of implementing them in practice.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/761449-episode-55-data-monitoring-committees.mp3" length="25664593" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-761449</guid>
    <pubDate>Fri, 27 Jul 2018 00:00:00 -0400</pubDate>
    <itunes:duration>3199</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 54: Statistics Without Borders</itunes:title>
    <title>Episode 54: Statistics Without Borders</title>
    <itunes:summary><![CDATA[Cathy Furlong and Gary Shapiro discuss the history of Statistics Without Borders and how statisticians can use their skills to give back to the community.]]></itunes:summary>
    <description><![CDATA[Cathy Furlong and Gary Shapiro discuss the history of Statistics Without Borders and how statisticians can use their skills to give back to the community.]]></description>
    <content:encoded><![CDATA[Cathy Furlong and Gary Shapiro discuss the history of Statistics Without Borders and how statisticians can use their skills to give back to the community.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/739152-episode-54-statistics-without-borders.mp3" length="23771264" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-739152</guid>
    <pubDate>Fri, 29 Jun 2018 00:00:00 -0400</pubDate>
    <itunes:duration>2954</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 53: Abuse Deterrent Opioids</itunes:title>
    <title>Episode 53: Abuse Deterrent Opioids</title>
    <itunes:summary><![CDATA[Ling Chen and Kunthel By discuss methods related to the development of abuse deterrent opioids.]]></itunes:summary>
    <description><![CDATA[Ling Chen and Kunthel By discuss methods related to the development of abuse deterrent opioids.]]></description>
    <content:encoded><![CDATA[Ling Chen and Kunthel By discuss methods related to the development of abuse deterrent opioids.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/716165-episode-53-abuse-deterrent-opioids.mp3" length="21072000" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-716165</guid>
    <pubDate>Thu, 31 May 2018 00:00:00 -0400</pubDate>
    <itunes:duration>2616</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 52: ASA Accreditation</itunes:title>
    <title>Episode 52: ASA Accreditation</title>
    <itunes:summary><![CDATA[Zoltan Harsanyi, Janet McDougall, and Theresa Utlaut discuss the PStat® and GStat® accreditations.]]></itunes:summary>
    <description><![CDATA[Zoltan Harsanyi, Janet McDougall, and Theresa Utlaut discuss the PStat® and GStat® accreditations.]]></description>
    <content:encoded><![CDATA[Zoltan Harsanyi, Janet McDougall, and Theresa Utlaut discuss the PStat® and GStat® accreditations.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/691192-episode-52-asa-accreditation.mp3" length="34064512" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-691192</guid>
    <pubDate>Fri, 27 Apr 2018 00:00:00 -0400</pubDate>
    <itunes:duration>4240</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 51: The Effective Statistician</itunes:title>
    <title>Episode 51: The Effective Statistician</title>
    <itunes:summary><![CDATA[Alexander Schacht and Benjamin Piske discuss their new podcast and the many ways statisticians can make themselves more effective.]]></itunes:summary>
    <description><![CDATA[Alexander Schacht and Benjamin Piske discuss their new podcast and the many ways statisticians can make themselves more effective.]]></description>
    <content:encoded><![CDATA[Alexander Schacht and Benjamin Piske discuss their new podcast and the many ways statisticians can make themselves more effective.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/671526-episode-51-the-effective-statistician.mp3" length="22542464" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-671526</guid>
    <pubDate>Wed, 28 Mar 2018 00:00:00 -0400</pubDate>
    <itunes:duration>2808</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 50: Lisa LaVange</itunes:title>
    <title>Episode 50: Lisa LaVange</title>
    <itunes:summary><![CDATA[ASA President Lisa LaVange describes her varied career across industry, government and academia, and discusses the establishment of the ASA Leadership Institute.]]></itunes:summary>
    <description><![CDATA[ASA President Lisa LaVange describes her varied career across industry, government and academia, and discusses the establishment of the ASA Leadership Institute.]]></description>
    <content:encoded><![CDATA[ASA President Lisa LaVange describes her varied career across industry, government and academia, and discusses the establishment of the ASA Leadership Institute.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/647550-episode-50-lisa-lavange.mp3" length="24510592" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-647550</guid>
    <pubDate>Wed, 21 Feb 2018 00:00:00 -0500</pubDate>
    <itunes:duration>3054</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 49: Heather Thomas</itunes:title>
    <title>Episode 49: Heather Thomas</title>
    <itunes:summary><![CDATA[Heather discusses her goals for the Biopharmaceutical Section in 2018 and describes the life of a medical product statistician living in a non-traditional area.]]></itunes:summary>
    <description><![CDATA[Heather discusses her goals for the Biopharmaceutical Section in 2018 and describes the life of a medical product statistician living in a non-traditional area.]]></description>
    <content:encoded><![CDATA[Heather discusses her goals for the Biopharmaceutical Section in 2018 and describes the life of a medical product statistician living in a non-traditional area.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/631192-episode-49-heather-thomas.mp3" length="22886528" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-631192</guid>
    <pubDate>Thu, 25 Jan 2018 00:00:00 -0500</pubDate>
    <itunes:duration>2851</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 48: PhUSE, the Pharmaceutical Users Software Exchange</itunes:title>
    <title>Episode 48: PhUSE, the Pharmaceutical Users Software Exchange</title>
    <itunes:summary><![CDATA[Stephen Bamford, Chris Hurley and James Johnson discuss the motivation for and initiatives of PhUSE]]></itunes:summary>
    <description><![CDATA[Stephen Bamford, Chris Hurley and James Johnson discuss the motivation for and initiatives of PhUSE]]></description>
    <content:encoded><![CDATA[Stephen Bamford, Chris Hurley and James Johnson discuss the motivation for and initiatives of PhUSE]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/602914-episode-48-phuse-the-pharmaceutical-users-software-exchange.mp3" length="24895616" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-602914</guid>
    <pubDate>Sat, 02 Dec 2017 00:00:00 -0500</pubDate>
    <itunes:duration>3102</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 47: Pediatric Medical Product Development</itunes:title>
    <title>Episode 47: Pediatric Medical Product Development</title>
    <itunes:summary><![CDATA[Susan Wang and Amy Xia discuss the challenges of pediatric medical product development.]]></itunes:summary>
    <description><![CDATA[Susan Wang and Amy Xia discuss the challenges of pediatric medical product development.]]></description>
    <content:encoded><![CDATA[Susan Wang and Amy Xia discuss the challenges of pediatric medical product development.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/590610-episode-47-pediatric-medical-product-development.mp3" length="22149248" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-590610</guid>
    <pubDate>Mon, 06 Nov 2017 00:00:00 -0500</pubDate>
    <itunes:duration>2759</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 46: Re-Randomization of Subjects Scientific Working Group</itunes:title>
    <title>Episode 46: Re-Randomization of Subjects Scientific Working Group</title>
    <itunes:summary><![CDATA[Gheorghe Doros, Anastasia Ivanova, and George Papakostas discuss the Sequential Parallel Comparison Design and the newly-formed Clinical Trial Designs with Re-Randomization of Subjects Scientific Working Group.]]></itunes:summary>
    <description><![CDATA[Gheorghe Doros, Anastasia Ivanova, and George Papakostas discuss the Sequential Parallel Comparison Design and the newly-formed Clinical Trial Designs with Re-Randomization of Subjects Scientific Working Group.]]></description>
    <content:encoded><![CDATA[Gheorghe Doros, Anastasia Ivanova, and George Papakostas discuss the Sequential Parallel Comparison Design and the newly-formed Clinical Trial Designs with Re-Randomization of Subjects Scientific Working Group.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/579762-episode-46-re-randomization-of-subjects-scientific-working-group.mp3" length="25647232" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-579762</guid>
    <pubDate>Sun, 15 Oct 2017 00:00:00 -0400</pubDate>
    <itunes:duration>3196</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 45: Kelly Zou</itunes:title>
    <title>Episode 45: Kelly Zou</title>
    <itunes:summary><![CDATA[Kelly shares her thoughts on real world data and real world evidence in the healthcare and pharmaceutical industry.]]></itunes:summary>
    <description><![CDATA[Kelly shares her thoughts on real world data and real world evidence in the healthcare and pharmaceutical industry.]]></description>
    <content:encoded><![CDATA[Kelly shares her thoughts on real world data and real world evidence in the healthcare and pharmaceutical industry.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/567031-episode-45-kelly-zou.mp3" length="11870336" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-567031</guid>
    <pubDate>Tue, 19 Sep 2017 00:00:00 -0400</pubDate>
    <itunes:duration>1474</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 44: Weili He and Martin Ho</itunes:title>
    <title>Episode 44: Weili He and Martin Ho</title>
    <itunes:summary><![CDATA[Weili and Martin discuss the 2017 Regulatory-Industry Statistics Workshop.]]></itunes:summary>
    <description><![CDATA[Weili and Martin discuss the 2017 Regulatory-Industry Statistics Workshop.]]></description>
    <content:encoded><![CDATA[Weili and Martin discuss the 2017 Regulatory-Industry Statistics Workshop.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/552997-episode-44-weili-he-and-martin-ho.mp3" length="17023104" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-552997</guid>
    <pubDate>Thu, 17 Aug 2017 00:00:00 -0400</pubDate>
    <itunes:duration>2118</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 43: 40th Anniversary of PSI</itunes:title>
    <title>Episode 43: 40th Anniversary of PSI</title>
    <itunes:summary><![CDATA[Andy Grieve, Nigel Howitt, John Lewis and Lucy Rowell reminisce about PSI’s past and look forward to its future.]]></itunes:summary>
    <description><![CDATA[Andy Grieve, Nigel Howitt, John Lewis and Lucy Rowell reminisce about PSI’s past and look forward to its future.]]></description>
    <content:encoded><![CDATA[Andy Grieve, Nigel Howitt, John Lewis and Lucy Rowell reminisce about PSI’s past and look forward to its future.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/542941-episode-43-40th-anniversary-of-psi.mp3" length="22960256" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-542941</guid>
    <pubDate>Thu, 27 Jul 2017 00:00:00 -0400</pubDate>
    <itunes:duration>2860</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 42: Committee on Minorities in Statistics</itunes:title>
    <title>Episode 42: Committee on Minorities in Statistics</title>
    <itunes:summary><![CDATA[Reneé Moore and Janelle Charles discuss the mission and major initiatives of the Committee on Minorities in Statistics and the many ways statisticians can get involved.]]></itunes:summary>
    <description><![CDATA[Reneé Moore and Janelle Charles discuss the mission and major initiatives of the Committee on Minorities in Statistics and the many ways statisticians can get involved.]]></description>
    <content:encoded><![CDATA[Reneé Moore and Janelle Charles discuss the mission and major initiatives of the Committee on Minorities in Statistics and the many ways statisticians can get involved.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/530907-episode-42-committee-on-minorities-in-statistics.mp3" length="22929536" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-530907</guid>
    <pubDate>Thu, 29 Jun 2017 00:00:00 -0400</pubDate>
    <itunes:duration>2857</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 41: Liz Stuart</itunes:title>
    <title>Episode 41: Liz Stuart</title>
    <itunes:summary><![CDATA[Liz discusses the Health Policy Statistics Section (HPSS) of the ASA, the upcoming 2018 International Conference on Health Policy Statistics (ICHPS), as well as some of the major topic areas of focus for health policy statistics.]]></itunes:summary>
    <description><![CDATA[Liz discusses the Health Policy Statistics Section (HPSS) of the ASA, the upcoming 2018 International Conference on Health Policy Statistics (ICHPS), as well as some of the major topic areas of focus for health policy statistics.]]></description>
    <content:encoded><![CDATA[Liz discusses the Health Policy Statistics Section (HPSS) of the ASA, the upcoming 2018 International Conference on Health Policy Statistics (ICHPS), as well as some of the major topic areas of focus for health policy statistics.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/521807-episode-41-liz-stuart.mp3" length="20308096" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-521807</guid>
    <pubDate>Mon, 05 Jun 2017 00:00:00 -0400</pubDate>
    <itunes:duration>2529</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 40: Estimands</itunes:title>
    <title>Episode 40: Estimands</title>
    <itunes:summary><![CDATA[Yuki Ando, Frank Bretz, Rob Hemmings and Tom Permutt discuss estimands and the ICH E9 revisions.]]></itunes:summary>
    <description><![CDATA[Yuki Ando, Frank Bretz, Rob Hemmings and Tom Permutt discuss estimands and the ICH E9 revisions.]]></description>
    <content:encoded><![CDATA[Yuki Ando, Frank Bretz, Rob Hemmings and Tom Permutt discuss estimands and the ICH E9 revisions.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/510706-episode-40-estimands.mp3" length="27254912" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-510706</guid>
    <pubDate>Mon, 08 May 2017 00:00:00 -0400</pubDate>
    <itunes:duration>3397</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 39: Alex Dmitrienko</itunes:title>
    <title>Episode 39: Alex Dmitrienko</title>
    <itunes:summary><![CDATA[Alex discusses multiplicity, the FDA’s draft guidance on multiple endpoints, and the BIOP pilot online training program.]]></itunes:summary>
    <description><![CDATA[Alex discusses multiplicity, the FDA’s draft guidance on multiple endpoints, and the BIOP pilot online training program.]]></description>
    <content:encoded><![CDATA[Alex discusses multiplicity, the FDA’s draft guidance on multiple endpoints, and the BIOP pilot online training program.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/488765-episode-39-alex-dmitrienko.mp3" length="27979904" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-488765</guid>
    <pubDate>Tue, 14 Mar 2017 00:00:00 -0400</pubDate>
    <itunes:duration>3488</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 38: Amanda Golbeck</itunes:title>
    <title>Episode 38: Amanda Golbeck</title>
    <itunes:summary><![CDATA[Amanda discusses statistical leadership and her book Leadership and Women in Statistics.]]></itunes:summary>
    <description><![CDATA[Amanda discusses statistical leadership and her book Leadership and Women in Statistics.]]></description>
    <content:encoded><![CDATA[Amanda discusses statistical leadership and her book Leadership and Women in Statistics.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/479530-episode-38-amanda-golbeck.mp3" length="16076928" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-479530</guid>
    <pubDate>Mon, 20 Feb 2017 00:00:00 -0500</pubDate>
    <itunes:duration>2000</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 37: Multiregional Clinical Trials</itunes:title>
    <title>Episode 37: Multiregional Clinical Trials</title>
    <itunes:summary><![CDATA[Aloka Chakravarty, Laurie Letvak and Bill Wang discuss MRCTs and the draft ICH E17 guidance.]]></itunes:summary>
    <description><![CDATA[Aloka Chakravarty, Laurie Letvak and Bill Wang discuss MRCTs and the draft ICH E17 guidance.]]></description>
    <content:encoded><![CDATA[Aloka Chakravarty, Laurie Letvak and Bill Wang discuss MRCTs and the draft ICH E17 guidance.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/467468-episode-37-multiregional-clinical-trials.mp3" length="29466752" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-467468</guid>
    <pubDate>Thu, 26 Jan 2017 00:00:00 -0500</pubDate>
    <itunes:duration>3674</itunes:duration>
    <itunes:keywords>Biopharmaceutical, statistics, FDA</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 36: Statistical Leadership</itunes:title>
    <title>Episode 36: Statistical Leadership</title>
    <itunes:summary><![CDATA[Sonia Davis, Bill Sollecito and Paula Brown Stafford discuss statistical leadership and leadership training at the University of North Carolina at Chapel Hill.]]></itunes:summary>
    <description><![CDATA[Sonia Davis, Bill Sollecito and Paula Brown Stafford discuss statistical leadership and leadership training at the University of North Carolina at Chapel Hill.]]></description>
    <content:encoded><![CDATA[Sonia Davis, Bill Sollecito and Paula Brown Stafford discuss statistical leadership and leadership training at the University of North Carolina at Chapel Hill.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/454551-episode-36-statistical-leadership.mp3" length="28831872" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-454551</guid>
    <pubDate>Wed, 21 Dec 2016 00:00:00 -0500</pubDate>
    <itunes:duration>3594</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 35: EFSPI Benefit-Risk Working Group</itunes:title>
    <title>Episode 35: EFSPI Benefit-Risk Working Group</title>
    <itunes:summary><![CDATA[Alexander Schacht and Ian Hirsch discuss benefit-risk and the efforts of the EFSPI working group.]]></itunes:summary>
    <description><![CDATA[Alexander Schacht and Ian Hirsch discuss benefit-risk and the efforts of the EFSPI working group.]]></description>
    <content:encoded><![CDATA[Alexander Schacht and Ian Hirsch discuss benefit-risk and the efforts of the EFSPI working group.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/441414-episode-35-efspi-benefit-risk-working-group.mp3" length="21559424" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-441414</guid>
    <pubDate>Thu, 10 Nov 2016 00:00:00 -0500</pubDate>
    <itunes:duration>2685</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 34: Patient Preferences in Medical Product Evaluation</itunes:title>
    <title>Episode 34: Patient Preferences in Medical Product Evaluation</title>
    <itunes:summary><![CDATA[Telba Irony and Martin Ho discuss the important of patient preferences.]]></itunes:summary>
    <description><![CDATA[Telba Irony and Martin Ho discuss the important of patient preferences.]]></description>
    <content:encoded><![CDATA[Telba Irony and Martin Ho discuss the important of patient preferences.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/429672-episode-34-patient-preferences-in-medical-product-evaluation.mp3" length="22052992" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-429672</guid>
    <pubDate>Fri, 07 Oct 2016 00:00:00 -0400</pubDate>
    <itunes:duration>2747</itunes:duration>
    <itunes:keywords>ASA, biopharmaceutical, biostatistics</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 33: Freda Cooner and Ed Luo</itunes:title>
    <title>Episode 33: Freda Cooner and Ed Luo</title>
    <itunes:summary><![CDATA[Freda and Ed discuss what to expect at the 2016 Biopharm Workshop]]></itunes:summary>
    <description><![CDATA[Freda and Ed discuss what to expect at the 2016 Biopharm Workshop]]></description>
    <content:encoded><![CDATA[Freda and Ed discuss what to expect at the 2016 Biopharm Workshop]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/419125-episode-33-freda-cooner-and-ed-luo.mp3" length="9631872" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-419125</guid>
    <pubDate>Tue, 06 Sep 2016 00:00:00 -0400</pubDate>
    <itunes:duration>1194</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 32: Marisa Bacchi</itunes:title>
    <title>Episode 32: Marisa Bacchi</title>
    <itunes:summary><![CDATA[Marisa Bacchi discusses the first EFSPI workshop on regulatory statistics.]]></itunes:summary>
    <description><![CDATA[Marisa Bacchi discusses the first EFSPI workshop on regulatory statistics.]]></description>
    <content:encoded><![CDATA[Marisa Bacchi discusses the first EFSPI workshop on regulatory statistics.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/412163-episode-32-marisa-bacchi.mp3" length="19406976" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-412163</guid>
    <pubDate>Wed, 17 Aug 2016 00:00:00 -0400</pubDate>
    <itunes:duration>2416</itunes:duration>
    <itunes:keywords>American statistical association, biopharmaceutical</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 31: Data Science</itunes:title>
    <title>Episode 31: Data Science</title>
    <itunes:summary><![CDATA[Marie Davidian, Montse Fuentes &amp; Mladen Vouk define data science, discuss related ASA initiatives and describe the data science program at NC State.

 ]]></itunes:summary>
    <description><![CDATA[Marie Davidian, Montse Fuentes &amp; Mladen Vouk define data science, discuss related ASA initiatives and describe the data science program at NC State.

 ]]></description>
    <content:encoded><![CDATA[Marie Davidian, Montse Fuentes &amp; Mladen Vouk define data science, discuss related ASA initiatives and describe the data science program at NC State.

 ]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/401441-episode-31-data-science.mp3" length="22632576" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-401441</guid>
    <pubDate>Thu, 14 Jul 2016 00:00:00 -0400</pubDate>
    <itunes:duration>2820</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 30: Women in Statistics and Data Science Conference </itunes:title>
    <title>Episode 30: Women in Statistics and Data Science Conference </title>
    <itunes:summary><![CDATA[Donna LaLonde, Dalene Stangl &amp; Jiayang Sun discuss the origins and program for the upcoming WSDS conference.]]></itunes:summary>
    <description><![CDATA[Donna LaLonde, Dalene Stangl &amp; Jiayang Sun discuss the origins and program for the upcoming WSDS conference.]]></description>
    <content:encoded><![CDATA[Donna LaLonde, Dalene Stangl &amp; Jiayang Sun discuss the origins and program for the upcoming WSDS conference.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/385378-episode-30-women-in-statistics-and-data-science-conference.mp3" length="15927424" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-385378</guid>
    <pubDate>Wed, 25 May 2016 00:00:00 -0400</pubDate>
    <itunes:duration>1981</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 29: Statistics and Pharmacometrics Interest Group</itunes:title>
    <title>Episode 29: Statistics and Pharmacometrics Interest Group</title>
    <itunes:summary><![CDATA[Alan Hartford and Matt Rotelli discuss the mission of the group and the importance of communication between statisticians and pharmacometricians.]]></itunes:summary>
    <description><![CDATA[Alan Hartford and Matt Rotelli discuss the mission of the group and the importance of communication between statisticians and pharmacometricians.]]></description>
    <content:encoded><![CDATA[Alan Hartford and Matt Rotelli discuss the mission of the group and the importance of communication between statisticians and pharmacometricians.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/377119-episode-29-statistics-and-pharmacometrics-interest-group.mp3" length="16695424" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-377119</guid>
    <pubDate>Sat, 30 Apr 2016 00:00:00 -0400</pubDate>
    <itunes:duration>2077</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 28: The Caucus for Women in Statistics</itunes:title>
    <title>Episode 28: The Caucus for Women in Statistics</title>
    <itunes:summary><![CDATA[Nancy Flournoy, Ji-Hyun Lee, Paula Roberson and Jiayang Sun discuss the goals and activities of the caucus.]]></itunes:summary>
    <description><![CDATA[Nancy Flournoy, Ji-Hyun Lee, Paula Roberson and Jiayang Sun discuss the goals and activities of the caucus.]]></description>
    <content:encoded><![CDATA[Nancy Flournoy, Ji-Hyun Lee, Paula Roberson and Jiayang Sun discuss the goals and activities of the caucus.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/366004-episode-28-the-caucus-for-women-in-statistics.mp3" length="27394176" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">Buzzsprout-366004</guid>
    <pubDate>Fri, 25 Mar 2016 00:00:00 -0400</pubDate>
    <itunes:duration>3418</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 27: Veronica Taylor</itunes:title>
    <title>Episode 27: Veronica Taylor</title>
    <itunes:summary><![CDATA[Veronica discusses the Center for Veterinary Medicine at FDA.]]></itunes:summary>
    <description><![CDATA[Veronica discusses the Center for Veterinary Medicine at FDA.]]></description>
    <content:encoded><![CDATA[Veronica discusses the Center for Veterinary Medicine at FDA.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/341793-episode-27-veronica-taylor.mp3" length="16435328" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">341793</guid>
    <pubDate>Tue, 12 Jan 2016 00:00:00 -0500</pubDate>
    <itunes:duration>2048</itunes:duration>
    <itunes:keywords>biopharmaceutical, statistics, FDA,veterinary medicine </itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 26: Data Transparency </itunes:title>
    <title>Episode 26: Data Transparency </title>
    <itunes:summary><![CDATA[Michael Hale, Jonathan Hartzel, Sara Hughes, Ted Lystig &amp; Estelle Russek-Cohen discuss the implications of data transparency for the pharmaceutical industry.]]></itunes:summary>
    <description><![CDATA[Michael Hale, Jonathan Hartzel, Sara Hughes, Ted Lystig &amp; Estelle Russek-Cohen discuss the implications of data transparency for the pharmaceutical industry.]]></description>
    <content:encoded><![CDATA[Michael Hale, Jonathan Hartzel, Sara Hughes, Ted Lystig &amp; Estelle Russek-Cohen discuss the implications of data transparency for the pharmaceutical industry.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/334093-episode-26-data-transparency.mp3" length="22608000" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">334093</guid>
    <pubDate>Tue, 15 Dec 2015 00:00:00 -0500</pubDate>
    <itunes:duration>2820</itunes:duration>
    <itunes:keywords>ASA, biopharm, statistics</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 25: Interview with Greg Campbell</itunes:title>
    <title>Episode 25: Interview with Greg Campbell</title>
    <itunes:summary><![CDATA[Greg Campbell discusses his career at the FDA and shares his thoughts on the future of medical product development.]]></itunes:summary>
    <description><![CDATA[Greg Campbell discusses his career at the FDA and shares his thoughts on the future of medical product development.]]></description>
    <content:encoded><![CDATA[Greg Campbell discusses his career at the FDA and shares his thoughts on the future of medical product development.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/323317-episode-25-interview-with-greg-campbell.mp3" length="24068224" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">323317</guid>
    <pubDate>Mon, 09 Nov 2015 00:00:00 -0500</pubDate>
    <itunes:duration>3003</itunes:duration>
    <itunes:keywords>ASA, Biopharmaceutical,  FDA</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 24: International Society for Biopharmaceutical Statistics</itunes:title>
    <title>Episode 24: International Society for Biopharmaceutical Statistics</title>
    <itunes:summary><![CDATA[Amit Bhattacharyya, Jie Chen, Frank Fan &amp; Yang Song discuss the mission of the ISBS and the regulatory environment in China.]]></itunes:summary>
    <description><![CDATA[Amit Bhattacharyya, Jie Chen, Frank Fan &amp; Yang Song discuss the mission of the ISBS and the regulatory environment in China.]]></description>
    <content:encoded><![CDATA[Amit Bhattacharyya, Jie Chen, Frank Fan &amp; Yang Song discuss the mission of the ISBS and the regulatory environment in China.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/313300-episode-24-international-society-for-biopharmaceutical-statistics.mp3" length="17971328" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">313300</guid>
    <pubDate>Tue, 06 Oct 2015 00:00:00 -0400</pubDate>
    <itunes:duration>2240</itunes:duration>
    <itunes:keywords>Biopharmaceutical, statistics, ASA</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 23: Wei Zhang and Richard Zink</itunes:title>
    <title>Episode 23: Wei Zhang and Richard Zink</title>
    <itunes:summary><![CDATA[Wei and Richard discuss the 2015 ASA Biopharmaceutical Section Statistics Workshop. Rima Izem conducts the interview.]]></itunes:summary>
    <description><![CDATA[Wei and Richard discuss the 2015 ASA Biopharmaceutical Section Statistics Workshop. Rima Izem conducts the interview.]]></description>
    <content:encoded><![CDATA[Wei and Richard discuss the 2015 ASA Biopharmaceutical Section Statistics Workshop. Rima Izem conducts the interview.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/298925-episode-23-wei-zhang-and-richard-zink.mp3" length="14131328" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/298925-episode-23-wei-zhang-and-richard-zink.mp3</guid>
    <pubDate>Tue, 18 Aug 2015 00:00:00 -0400</pubDate>
    <itunes:duration>1755</itunes:duration>
    <itunes:keywords>biopharmaceutical, ASA, biostatistics</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 22: Qi Jiang and Olga Marchenko</itunes:title>
    <title>Episode 22: Qi Jiang and Olga Marchenko</title>
    <itunes:summary><![CDATA[Qi and Olga discuss the first scientific working group of the ASA Biopharmaceutical Section.]]></itunes:summary>
    <description><![CDATA[Qi and Olga discuss the first scientific working group of the ASA Biopharmaceutical Section.]]></description>
    <content:encoded><![CDATA[Qi and Olga discuss the first scientific working group of the ASA Biopharmaceutical Section.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/264100-episode-22-qi-jiang-and-olga-marchenko.mp3" length="11458688" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/264100-episode-22-qi-jiang-and-olga-marchenko.mp3</guid>
    <pubDate>Fri, 17 Apr 2015 00:00:00 -0400</pubDate>
    <itunes:duration>1426</itunes:duration>
    <itunes:keywords>ASA biopharm, biostatistics</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 21:  Interview with Dionne Price</itunes:title>
    <title>Episode 21:  Interview with Dionne Price</title>
    <itunes:summary><![CDATA[As current Chair for the Biopharmaceutical Section, Dionne discusses her goals for the upcoming year.]]></itunes:summary>
    <description><![CDATA[As current Chair for the Biopharmaceutical Section, Dionne discusses her goals for the upcoming year.]]></description>
    <content:encoded><![CDATA[As current Chair for the Biopharmaceutical Section, Dionne discusses her goals for the upcoming year.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/249912-episode-21-interview-with-dionne-price.mp3" length="9910400" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/249912-episode-21-interview-with-dionne-price.mp3</guid>
    <pubDate>Fri, 27 Feb 2015 00:00:00 -0500</pubDate>
    <itunes:duration>1233</itunes:duration>
    <itunes:keywords>biopharmaceutical, statistics, american statistical association</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 20:  Interview with Chrissie Fletcher</itunes:title>
    <title>Episode 20:  Interview with Chrissie Fletcher</title>
    <itunes:summary><![CDATA[Chrissie Fletcher discusses EFSPI, the European Federation of Statisticians in the Pharmaceutical Industry.]]></itunes:summary>
    <description><![CDATA[Chrissie Fletcher discusses EFSPI, the European Federation of Statisticians in the Pharmaceutical Industry.]]></description>
    <content:encoded><![CDATA[Chrissie Fletcher discusses EFSPI, the European Federation of Statisticians in the Pharmaceutical Industry.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/234496-episode-20-interview-with-chrissie-fletcher.mp3" length="9982080" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/234496-episode-20-interview-with-chrissie-fletcher.mp3</guid>
    <pubDate>Tue, 06 Jan 2015 00:00:00 -0500</pubDate>
    <itunes:duration>1242</itunes:duration>
    <itunes:keywords>ASA, biostatistics, Biopharmaceutical</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 19:   Interview with Zoran Antonijevic</itunes:title>
    <title>Episode 19:   Interview with Zoran Antonijevic</title>
    <itunes:summary><![CDATA[Zoran Antonijevic discusses the DIA Scientific Working Group on Adaptive Designs, and the upcoming Joint Adaptive Design and Bayesian Statistics Conference in Feb 2015.]]></itunes:summary>
    <description><![CDATA[Zoran Antonijevic discusses the DIA Scientific Working Group on Adaptive Designs, and the upcoming Joint Adaptive Design and Bayesian Statistics Conference in Feb 2015.]]></description>
    <content:encoded><![CDATA[Zoran Antonijevic discusses the DIA Scientific Working Group on Adaptive Designs, and the upcoming Joint Adaptive Design and Bayesian Statistics Conference in Feb 2015.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/227221-episode-19-interview-with-zoran-antonijevic.mp3" length="10823808" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/227221-episode-19-interview-with-zoran-antonijevic.mp3</guid>
    <pubDate>Mon, 08 Dec 2014 00:00:00 -0500</pubDate>
    <itunes:duration>1347</itunes:duration>
    <itunes:keywords>biostatistics, ASA, adaptive design, Bayesian</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 18: Interview with Amarjot Kaur</itunes:title>
    <title>Episode 18: Interview with Amarjot Kaur</title>
    <itunes:summary><![CDATA[Amarjot Kaur discusses the new mentoring program of the ASA Biopharmaceutical Section.]]></itunes:summary>
    <description><![CDATA[Amarjot Kaur discusses the new mentoring program of the ASA Biopharmaceutical Section.]]></description>
    <content:encoded><![CDATA[Amarjot Kaur discusses the new mentoring program of the ASA Biopharmaceutical Section.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/222302-episode-18-interview-with-amarjot-kaur.mp3" length="13039744" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/222302-episode-18-interview-with-amarjot-kaur.mp3</guid>
    <pubDate>Wed, 19 Nov 2014 00:00:00 -0500</pubDate>
    <itunes:duration>1624</itunes:duration>
    <itunes:keywords>ASA, biopharmaceutical statistics</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 17: A Conversation with Bob O’Neill</itunes:title>
    <title>Episode 17: A Conversation with Bob O’Neill</title>
    <itunes:summary><![CDATA[A recording of A Conversation with Bob O'Neill which took place during a recent ASA Boston Chapter meeting.   Dr. O’Neill discusses aspects of the past, present, and future of regulatory statistics in an interview format with Dr. Scott Evans. Topics include: Dr. O’Neill’s view of challenging issues of the future, key challenges for the FDA during his tenure, and training in regulatory statistics and decision making. ]]></itunes:summary>
    <description><![CDATA[A recording of A Conversation with Bob O&apos;Neill which took place during a recent ASA Boston Chapter meeting.   Dr. O’Neill discusses aspects of the past, present, and future of regulatory statistics in an interview format with Dr. Scott Evans. Topics include: Dr. O’Neill’s view of challenging issues of the future, key challenges for the FDA during his tenure, and training in regulatory statistics and decision making. ]]></description>
    <content:encoded><![CDATA[A recording of A Conversation with Bob O&apos;Neill which took place during a recent ASA Boston Chapter meeting.   Dr. O’Neill discusses aspects of the past, present, and future of regulatory statistics in an interview format with Dr. Scott Evans. Topics include: Dr. O’Neill’s view of challenging issues of the future, key challenges for the FDA during his tenure, and training in regulatory statistics and decision making. ]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/213936-episode-17-a-conversation-with-bob-o-neill.mp3" length="49979520" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/213936-episode-17-a-conversation-with-bob-o-neill.mp3</guid>
    <pubDate>Mon, 20 Oct 2014 00:00:00 -0400</pubDate>
    <itunes:duration>6242</itunes:duration>
    <itunes:keywords>ASA, biostatistics, pharmaceutical statistics, applied statistics, statistics</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 16: Interview with Ted Lystig</itunes:title>
    <title>Episode 16: Interview with Ted Lystig</title>
    <itunes:summary><![CDATA[Ted Lystig discusses some of the unique challenges present in the development of medical devices, and the recent formation of the new ASA Section on Medical Devices and Diagnostics.]]></itunes:summary>
    <description><![CDATA[Ted Lystig discusses some of the unique challenges present in the development of medical devices, and the recent formation of the new ASA Section on Medical Devices and Diagnostics.]]></description>
    <content:encoded><![CDATA[Ted Lystig discusses some of the unique challenges present in the development of medical devices, and the recent formation of the new ASA Section on Medical Devices and Diagnostics.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/208280-episode-16-interview-with-ted-lystig.mp3" length="9543808" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/208280-episode-16-interview-with-ted-lystig.mp3</guid>
    <pubDate>Mon, 29 Sep 2014 00:00:00 -0400</pubDate>
    <itunes:duration>1187</itunes:duration>
    <itunes:keywords>biostatistics, biopharmaceutical, American statistical association</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 15: Interview with Cristiana Mayer and Shiowjen Lee</itunes:title>
    <title>Episode 15: Interview with Cristiana Mayer and Shiowjen Lee</title>
    <itunes:summary><![CDATA[Cristiana and Shiowjen discuss the 2014 ASA Biopharm Section FDA-Industry Statistics Workshop.]]></itunes:summary>
    <description><![CDATA[Cristiana and Shiowjen discuss the 2014 ASA Biopharm Section FDA-Industry Statistics Workshop.]]></description>
    <content:encoded><![CDATA[Cristiana and Shiowjen discuss the 2014 ASA Biopharm Section FDA-Industry Statistics Workshop.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/200243-episode-15-interview-with-cristiana-mayer-and-shiowjen-lee.mp3" length="14753920" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/200243-interview-with-cristiana-mayer-and-shiowjen-lee.mp3</guid>
    <pubDate>Fri, 29 Aug 2014 00:00:00 -0400</pubDate>
    <itunes:duration>1838</itunes:duration>
    <itunes:keywords>statistics, ASA, biopharmaceutical statistics</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 14: Interview with Biopharm Program Chair Ivan Chan </itunes:title>
    <title>Episode 14: Interview with Biopharm Program Chair Ivan Chan </title>
    <itunes:summary><![CDATA[Ivan Chan discusses Biopharm Section activities at the 2014 Joint Statistical Meetings in Boston.]]></itunes:summary>
    <description><![CDATA[Ivan Chan discusses Biopharm Section activities at the 2014 Joint Statistical Meetings in Boston.]]></description>
    <content:encoded><![CDATA[Ivan Chan discusses Biopharm Section activities at the 2014 Joint Statistical Meetings in Boston.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/188905-episode-14-interview-with-biopharm-program-chair-ivan-chan.mp3" length="6789248" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/188905-interview-with-biopharm-program-chair-ivan-chan.mp3</guid>
    <pubDate>Mon, 14 Jul 2014 00:00:00 -0400</pubDate>
    <itunes:duration>843</itunes:duration>
    <itunes:keywords>JSM, ASA, Biopharmaceutical, Statistics</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 13: American Statistical Association 175th Anniversary Discussion</itunes:title>
    <title>Episode 13: American Statistical Association 175th Anniversary Discussion</title>
    <itunes:summary></itunes:summary>
    <description></description>
    <content:encoded></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/184849-episode-13-american-statistical-association-175th-anniversary-discussion.mp3" length="11434112" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/184849-american-statistical-association-175th-anniversary-discussion.mp3</guid>
    <pubDate>Thu, 26 Jun 2014 00:00:00 -0400</pubDate>
    <itunes:duration>1423</itunes:duration>
    <itunes:keywords>ASA, biopharmaceutical, Statistics</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 12: Interview with Statisticians in the Pharmaceutical Industry (PSI)</itunes:title>
    <title>Episode 12: Interview with Statisticians in the Pharmaceutical Industry (PSI)</title>
    <itunes:summary><![CDATA[The past, current and chair-elect of PSI (Katherine Hutchinson, Robert Cuffe and Mark Morris, respectively) describe the history of the organization and discuss differences in the regulatory experience between the U.S. and E.U.]]></itunes:summary>
    <description><![CDATA[The past, current and chair-elect of PSI (Katherine Hutchinson, Robert Cuffe and Mark Morris, respectively) describe the history of the organization and discuss differences in the regulatory experience between the U.S. and E.U.]]></description>
    <content:encoded><![CDATA[The past, current and chair-elect of PSI (Katherine Hutchinson, Robert Cuffe and Mark Morris, respectively) describe the history of the organization and discuss differences in the regulatory experience between the U.S. and E.U.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/175484-episode-12-interview-with-statisticians-in-the-pharmaceutical-industry-psi.mp3" length="11225216" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/175484-interview-with-statisticians-in-the-pharmaceutical-industry-psi.mp3</guid>
    <pubDate>Tue, 20 May 2014 00:00:00 -0400</pubDate>
    <itunes:duration>1397</itunes:duration>
    <itunes:keywords>statistics, pharmaceutical, quantitative science</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 11: Interview with ASA Biopharmaceutical Section Chair Matilde Sanchez-Kam</itunes:title>
    <title>Episode 11: Interview with ASA Biopharmaceutical Section Chair Matilde Sanchez-Kam</title>
    <itunes:summary><![CDATA[Biopharmaceutical Section Chair Matilde Sanchez-Kam talks about the challenges of a small pharmaceutical company, volunteering with the section, and building collaborations with other statistics organizations.]]></itunes:summary>
    <description><![CDATA[Biopharmaceutical Section Chair Matilde Sanchez-Kam talks about the challenges of a small pharmaceutical company, volunteering with the section, and building collaborations with other statistics organizations.]]></description>
    <content:encoded><![CDATA[Biopharmaceutical Section Chair Matilde Sanchez-Kam talks about the challenges of a small pharmaceutical company, volunteering with the section, and building collaborations with other statistics organizations.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/167019-episode-11-interview-with-asa-biopharmaceutical-section-chair-matilde-sanchez-kam.mp3" length="6033536" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/167019-interview-with-asa-biopharmaceutical-section-chair-matilde-sanchez-kam.mp3</guid>
    <pubDate>Fri, 18 Apr 2014 00:00:00 -0400</pubDate>
    <itunes:duration>748</itunes:duration>
    <itunes:keywords>statistics, biopharmaceutical, biostatistics, American Statistical Association</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 10: Bayesian Methods</itunes:title>
    <title>Episode 10: Bayesian Methods</title>
    <itunes:summary><![CDATA[Karen Price talks about all things Bayesian in the world of pharmaceutical development:  methodology, the DIA Bayesian Scientific Working Group, and the special Bayesian issue of Pharmaceutical Statistics.]]></itunes:summary>
    <description><![CDATA[Karen Price talks about all things Bayesian in the world of pharmaceutical development:  methodology, the DIA Bayesian Scientific Working Group, and the special Bayesian issue of Pharmaceutical Statistics.]]></description>
    <content:encoded><![CDATA[Karen Price talks about all things Bayesian in the world of pharmaceutical development:  methodology, the DIA Bayesian Scientific Working Group, and the special Bayesian issue of Pharmaceutical Statistics.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/161392-episode-10-bayesian-methods.mp3" length="8740992" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/161392-bayesian-methods.mp3</guid>
    <pubDate>Fri, 28 Mar 2014 00:00:00 -0400</pubDate>
    <itunes:duration>1087</itunes:duration>
    <itunes:keywords>Bayesian statistics, pharmaceutical statistics, quantitative science</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 9: Trends and Innovations in Clinical Trial Statistics Conference</itunes:title>
    <title>Episode 9: Trends and Innovations in Clinical Trial Statistics Conference</title>
    <itunes:summary><![CDATA[Olga Marchenko from Quintiles gives a brief overview of the upcoming Trends and Innovations in Clinical Trial Statistics Conference to take place April 21-23 in Research Triangle Park, North Carolina.]]></itunes:summary>
    <description><![CDATA[Olga Marchenko from Quintiles gives a brief overview of the upcoming Trends and Innovations in Clinical Trial Statistics Conference to take place April 21-23 in Research Triangle Park, North Carolina.]]></description>
    <content:encoded><![CDATA[Olga Marchenko from Quintiles gives a brief overview of the upcoming Trends and Innovations in Clinical Trial Statistics Conference to take place April 21-23 in Research Triangle Park, North Carolina.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/153474-episode-9-trends-and-innovations-in-clinical-trial-statistics-conference.mp3" length="5005440" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/153474-trends-and-innovations-in-clinical-trial-statistics-conference.mp3</guid>
    <pubDate>Tue, 25 Feb 2014 00:00:00 -0500</pubDate>
    <itunes:duration>620</itunes:duration>
    <itunes:keywords>statistics, clinical trials</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 8: Interview with Nate Silver</itunes:title>
    <title>Episode 8: Interview with Nate Silver</title>
    <itunes:summary><![CDATA[Nate Silver talks prediction, Bayesian methods, communicating statistical ideas to the general public and how to better educate people in statistical thinking.  ]]></itunes:summary>
    <description><![CDATA[Nate Silver talks prediction, Bayesian methods, communicating statistical ideas to the general public and how to better educate people in statistical thinking.  ]]></description>
    <content:encoded><![CDATA[Nate Silver talks prediction, Bayesian methods, communicating statistical ideas to the general public and how to better educate people in statistical thinking.  ]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/123680-episode-8-interview-with-nate-silver.mp3" length="8335488" type="audio/mpeg" />
    <itunes:author>American Statistical Association (ASA) Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/123680-interview-with-nate-silver.mp3</guid>
    <pubDate>Fri, 18 Oct 2013 00:00:00 -0400</pubDate>
    <itunes:duration>1036</itunes:duration>
    <itunes:keywords>Nate Silver, Statistics, prediction, variability</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 7: An interview with Ben Locwin</itunes:title>
    <title>Episode 7: An interview with Ben Locwin</title>
    <itunes:summary><![CDATA[Ben Locwin discusses data quality and why he thinks statistics is a requirement for good science.]]></itunes:summary>
    <description><![CDATA[Ben Locwin discusses data quality and why he thinks statistics is a requirement for good science.]]></description>
    <content:encoded><![CDATA[Ben Locwin discusses data quality and why he thinks statistics is a requirement for good science.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/118680-episode-7-an-interview-with-ben-locwin.mp3" length="5386368" type="audio/mpeg" />
    <itunes:author>ASA Biopharm. Section</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/118680-an-interview-with-ben-locwin-of-lonza-biopharmaceuticals.mp3</guid>
    <pubDate>Tue, 01 Oct 2013 00:00:00 -0400</pubDate>
    <itunes:duration>669</itunes:duration>
    <itunes:keywords>statistics, science, ASA, Biopharm</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 6: Interview With Lily Yue and Bruce Binkowitz</itunes:title>
    <title>Episode 6: Interview With Lily Yue and Bruce Binkowitz</title>
    <itunes:summary></itunes:summary>
    <description></description>
    <content:encoded></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/112558-episode-6-interview-with-lily-yue-and-bruce-binkowitz.mp3" length="7268480" type="audio/mpeg" />
    <itunes:author>ASA Biopharm</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/112558-interview-with-lily-yue-fda-cdph-and-bruce-binkowitz-merck.mp3</guid>
    <pubDate>Wed, 04 Sep 2013 00:00:00 -0400</pubDate>
    <itunes:duration>908</itunes:duration>
    <itunes:keywords>FDA, Merck, FDA Industry Workshop 2013</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 5: Interview with Estelle Russek-Cohen</itunes:title>
    <title>Episode 5: Interview with Estelle Russek-Cohen</title>
    <itunes:summary></itunes:summary>
    <description></description>
    <content:encoded></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/112565-episode-5-interview-with-estelle-russek-cohen.mp3" length="3131520" type="audio/mpeg" />
    <itunes:author>ASA Biopharm</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/112565-joint-statistical-meeting-2013-interview-with-dr-russek-cohen.mp3</guid>
    <pubDate>Sat, 03 Aug 2013 00:00:00 -0400</pubDate>
    <itunes:duration>391</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 4: Interview with Amit Bhattacharyya</itunes:title>
    <title>Episode 4: Interview with Amit Bhattacharyya</title>
    <itunes:summary></itunes:summary>
    <description></description>
    <content:encoded></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/112566-episode-4-interview-with-amit-bhattacharyya.mp3" length="3037312" type="audio/mpeg" />
    <itunes:author>ASA Biopharm</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/112566-interview-with-amit-bhattacharyya-on-asa-biopharmaceutical-section.mp3</guid>
    <pubDate>Thu, 04 Jul 2013 00:00:00 -0400</pubDate>
    <itunes:duration>379</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 3: Interview with Stephen Senn </itunes:title>
    <title>Episode 3: Interview with Stephen Senn </title>
    <itunes:summary></itunes:summary>
    <description></description>
    <content:encoded></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/112570-episode-3-interview-with-stephen-senn.mp3" length="4245632" type="audio/mpeg" />
    <itunes:author>ASA Biopharm</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/112570-psi-2013-interview-with-stephen-senn.mp3</guid>
    <pubDate>Fri, 03 May 2013 00:00:00 -0400</pubDate>
    <itunes:duration>530</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 2: Interview with Jingyee Kou and Alan Hartford</itunes:title>
    <title>Episode 2: Interview with Jingyee Kou and Alan Hartford</title>
    <itunes:summary><![CDATA[Jingyee and Alan discuss the 2012 FDA-Industry Workshop.]]></itunes:summary>
    <description><![CDATA[Jingyee and Alan discuss the 2012 FDA-Industry Workshop.]]></description>
    <content:encoded><![CDATA[Jingyee and Alan discuss the 2012 FDA-Industry Workshop.]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/112980-episode-2-interview-with-jingyee-kou-and-alan-hartford.mp3" length="3827840" type="audio/mpeg" />
    <itunes:author>ASA Biopharm</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/112980-fda-industry-workshop-2012.mp3</guid>
    <pubDate>Thu, 06 Sep 2012 00:00:00 -0400</pubDate>
    <itunes:duration>478</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Episode 1: Special Issue on Nonclinical Biopharmaceutical Statistics </itunes:title>
    <title>Episode 1: Special Issue on Nonclinical Biopharmaceutical Statistics </title>
    <itunes:summary><![CDATA[Interview with Stan Altan &amp; Timothy L. Schofield]]></itunes:summary>
    <description><![CDATA[Interview with Stan Altan &amp; Timothy L. Schofield]]></description>
    <content:encoded><![CDATA[Interview with Stan Altan &amp; Timothy L. Schofield]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/16296/episodes/112981-episode-1-special-issue-on-nonclinical-biopharmaceutical-statistics.mp3" length="7813248" type="audio/mpeg" />
    <itunes:author>ASA Biopharm</itunes:author>
    <guid isPermaLink="false">http://www.buzzsprout.com/16296/112981-special-issue-on-nonclinical-biopharmaceutical-statistics.mp3</guid>
    <pubDate>Mon, 06 Aug 2012 00:00:00 -0400</pubDate>
    <itunes:duration>976</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
</channel>
</rss>
